US5194393A - Optical biosensor and method of use - Google Patents

Optical biosensor and method of use Download PDF

Info

Publication number
US5194393A
US5194393A US07/611,197 US61119790A US5194393A US 5194393 A US5194393 A US 5194393A US 61119790 A US61119790 A US 61119790A US 5194393 A US5194393 A US 5194393A
Authority
US
United States
Prior art keywords
film
dye
langmuir
molecule
layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US07/611,197
Inventor
Herbert Hugl
Eberhard Kuckert
Dietmar Mobius
Holger Ohst
Meinhard Rolf
Hans J. Rosenkranz
Heinrich C. Schopper
Hans-Ulrich Siegmund
Klaus Sommer
Rolf Wehrmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19893938598 external-priority patent/DE3938598A1/en
Priority claimed from DE19904013713 external-priority patent/DE4013713A1/en
Application filed by Bayer AG filed Critical Bayer AG
Assigned to BAYER AKTIENGESELLSCHAFT, LEVERKUSEN, GERMANY, A CORP. OF GERMANY reassignment BAYER AKTIENGESELLSCHAFT, LEVERKUSEN, GERMANY, A CORP. OF GERMANY ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: ROSENKRANZ, HANS J., SCHOPPER, HEINRICH C., ROLF, MEINHARD, OHST, HOLGER, MOBIUS, DIETMAR, KUCKERT, EBERHARD, HUGL, HERBERT
Application granted granted Critical
Publication of US5194393A publication Critical patent/US5194393A/en
Assigned to SIEMENS HEALTHCARE DIAGNOSTICS GMBH reassignment SIEMENS HEALTHCARE DIAGNOSTICS GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BAYER AG
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54373Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/552Glass or silica
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553Metal or metal coated
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G01N2021/6439Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
    • G01N2021/6441Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks with two or more labels
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/968High energy substrates, e.g. fluorescent, chemiluminescent, radioactive
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/80Fluorescent dyes, e.g. rhodamine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/805Optical property

Definitions

  • the present invention relates to an optical biosensor with a novel construction for a detection method for molecules which are labelled with a fluorescent dye for the detection of dissolved substances or dissolved analytes which behave, for example, like antigen and antibody.
  • This takes the form of a solid-phase sensor with fluorescent dye which permits an energy-transfer process to a molecule which is to be detected and is labelled with a second fluorescent dye.
  • Immunoassays in particular are outstanding as a sensitive detection method for the determination of very small amounts of organic substances. Immunoassay methods are generally based on the ability of a receptor molecule, for example of an antibody, to recognise specifically the structure and molecular organization of a ligand molecule, whether it is defined by non-polar and/or polar interactions, and to bind this molecule very specifically in such a manner.
  • Immunoassays are carried out by various methods. These include the use of various labelling techniques, usually of a radioactive, enzyme-coupled and fluorescent nature too (Methods in Enzymology, 74 (1981), 28-60) .
  • Some of these known immunoassay methods entail the use of fluorescent dye molecules F 1 which are able to absorb light of a wavelength ⁇ 1 and to emit light of a second, larger wavelength ⁇ 2 . Under certain conditions, in the presence of another fluorescent dye molecule F 2 , excitation of F 1 by light of the wavelength ⁇ 1 is followed by a radiationless energy transfer to F 2 which then in turn emits light of a third, even larger wavelength ⁇ 3 .
  • EP 150,905 describes an immunoassay operating in homogeneous solution, in which analyte or antigen has been labelled with a fluorescent dye F 1 and the antibody which binds specifically thereto has been provided with a fluorescent dye F 2 .
  • F 1 fluorescent dye
  • F 2 fluorescent dye
  • one of the two labelled binding partners is attached to a solid surface, and the correspondingly specifically binding partner is bound from a homogeneous solution.
  • the specific binding is detected as already explained above by an appropriate energy transfer by means of evanescent wave technology (Nature 320 (1986), 179-181).
  • a further disadvantage of the stated systems derives from the fact that complementary systems have in each case to be specifically labelled and thus versatile use is impossible.
  • Another disadvantage of these systems constructed in heterogeneous phase is the specific evanescent wave technique used.
  • the immobilization of the specifically binding molecules to the solid surface via a coupling component/antibody/antigen/antibody system entails very elaborate preparation.
  • Another disadvantage in principle of this solid-phase technology in immunoassays is the reproducible preparation of coatings of the assay matrix with the reactants in the immune reaction.
  • an essential quality feature for analytical methods is the reproducibility of the detection method.
  • the present invention relates to a sensor with a novel construction for a detection method of molecules labelled with fluorescent dye for detecting these dissolved substances or analytes by energy transfer with a simple fluorescence technique and increased sensitivity in the detection as well as versatile use for different tasks and the possibility of reproducible preparation of films bound to solid surfaces. Besides the distinct increase in sensitivity, all the disadvantages listed above are simultaneously avoided.
  • the invention relates to an optical biosensor based on fluorescence energy transfer, consisting of
  • e1 is covalently bonded to a ligand which is able to bind to the receptor, or which
  • e2 is covalently bonded to another receptor which is able to bind to the complex composed of the first receptor and ligand,
  • FIG. 1 is a schematic representation of the optical biosensor of the present invention.
  • Suitable supports are all supports which are known to the skilled worker and are suitable for the LB technique, such as glass, quartz glass, other glasses such as Li niobate, zinc selenide, porcelain, semiconductor materials such as germanium, GaAs or silicon, and metals.
  • plastics such as polymethylmethacrylate, polycarbonate, polystyrene and others, and metallized plastics.
  • the solid support materials can also be surface-modified before the coating, for example glass or quartz or silicon by pretreatment with trichloromethylsilane, dichlorodimethylsilane, trichlorooctadecylsilane, hexamethyldisilazane or by plasma etching or plasma polymerization.
  • the supports take the form of optionally surface-modified glass, quartz glass, silicon, plastic or a metallized plastic. Other preferred supports are optically transparent. All support materials are additionally distinguished by a uniform surface, preferably by a plane surface.
  • the LB technique means hereinafter a process for transferring monomolecular films from a liquid (water) surface to a solid support by the Langmuir-Blodgett process.
  • a solid support with an essentially smooth surface is dipped in a manner known per se through a compressed monomolecular film on the liquid surface and, in this way, this film is transferred to the support.
  • the immersion and emergence can take place at right angles or obliquely to the liquid surface. Furthermore, it is possible according to the Langmuir-Schafer technique for the support also to be contacted at a point or at an edge with the liquid surface and then pivoted onto the liquid surface. Finally, the support can also be lowered onto the liquid surface in a parallel manner ("horizontal dipping").
  • the transfer takes place at a temperature of 5°-40° C., preferably at room temperature.
  • These ordered LB films can consist of low molecular weight and/or polymeric amphiphiles, preferably of polymeric amphiphiles, and can contain covalently bonded fluorescent chromophore/dyes and/or amphiphilic fluorescent chromophore/dyes, which are called F 1 hereinafter.
  • LB films additionally contain or are covalently linked to functional molecules as receptors, for example glycolipids, poly- and oligonucleotides, proteins or fragments thereof, haptens and others.
  • functional molecules for example glycolipids, poly- and oligonucleotides, proteins or fragments thereof, haptens and others.
  • ligand molecule complementary thereto
  • F 2 a second fluorescent dye
  • the sensor construction described in this way is able in this function to detect not only an analyte present in solution and labelled with a fluorescent dye F 2 ; the sensor construction can also be used to detect in a competitive mode of functioning an analyte which is not fluorescent-labelled.
  • the specific binding sites of the functional molecules in the LB film are saturated with fluorescent-labelled molecules which bind complementarily.
  • Amphiphilic molecules that is to say molecules which have a hydrophilic end (a "head") and a hydrophobic end (a "tail”) are used for constructing LB films.
  • Such amphiphilic molecules can be low-molecular weight compounds with a molecular weight of up to about 2000 g/mol.
  • these low molecular weight amphiphiles can contain functional groups which are capable of polymerization or capable of polycondensation and polyaddition so that, after construction of the LB films from low molecular weight amphiphiles, these amphiphiles in the LB film can be linked in a subsequent reaction to give high molecular weight compounds. This subsequent reaction to give high molecular weight compounds is advantageous because LB films composed of polymeric amphiphiles have higher thermal and mechanical stabilities.
  • polymeric amphiphiles as are suitable for the optical biosensor according to the invention are a-olefin/maleic anhydride copolymers (British Polymer Journal 17 (1985), 368 et seq.; J. Macromol. Sci. Phys. B 23 (1985), 549-573), polyoctadecylmethacrylate, polyvinyl stearate (J. Coll. Interface Sci. 86 (1982), 485), polyvinylphospholipids (Angew. Chem. 100 (1988), 117-162), cellulose tristearate, amphiphilic polyamides (DE-OS (German Published Specification) 3,830,325) and acrylamide copolymers.
  • Suitable and preferred for the preparation of stable LB films are polyurethanes according to DE-OS (German Published Specification) 3,827,438 and polyesters according to DE-OS (German Published Specification) 3,830,862.
  • polymeric amphiphiles reference may also be made very especially to random poly(alkyl methacrylate) copolymers of the following type, whose composition can vary widely: ##STR1## in which R 1 , R 2 and R 3 represent, independently of one another, hydrogen or methyl,
  • R 4 is straight-chain C 14 -C 22 -alkyl
  • R 5 is the hydrogen, sodium or potassium ion or represents one of the groups --CH 2 --CH 2 OH, --CH 2 --CH 2 --NH-tertbutyl, --CH 2 --CH 2 --N(CH 3 ) 2 , ##STR2##
  • R 6 is a fluorescent chromophore which is known to the skilled worker and is represented hereinafter, and
  • y assumes a value of 0-0.8
  • x and y are approximately equal.
  • polymers of the formula (I) are the following: ##STR3##
  • the fluorescent chromophore is covalently linked to the amphiphilic polymer.
  • this arrangement allows the maximum possible stability of the F 1 -containing LB films, it is also possible, however, to obtain F 1 -containing LB films by spreading an amphiphilic polymer together with amphiphilic fluorescent dyes on the water surface before the coating process.
  • amphiphilic fluorescent dyes which can be used together with amphiphilic polymers which contain no chromophores are, for example, cyanine dyes of the types ##STR4## in which X and Y represent, independently of one another, oxygen, sulphur or selenium or C(CH 3 ) 2 ,
  • R 7 denotes hydrogen or methyl
  • R 8 and R 9 represent, independently of one another, straight-chain C 1 -C 22 -alkyl.
  • fluorescent dyes which are known in principle to the skilled worker and can be used according to the invention are dyes of the following types: ##STR5##
  • amphiphilic fluorescent dyes are described in the monograph Physical Methods of Chemistry, Vol. 1, Part. 3B, pages 577 et seq., John Wiley, New York 1972. If the intention is to introduce such amphiphilic fluorescent dyes into LB films, care must be taken that there is uniform distribution of the dye throughout the film. Thus, it is necessary to avoid the transfer of individual films taking place, depending on the temperature (typically 5°-40°, preferably about 20° C.), with such an applied thrust at which a coexistence region of the solid-analogous and liquid-analogous phase is passed through.
  • temperature typically 5°-40°, preferably about 20° C.
  • amphiphilic fluorescent dye does not, as a rule, have the same solubility in both phases and thus inhomogeneous films, which are less suitable for the sensor application, are formed.
  • This phenomenon is known for LB films composed of low molecular weight substances (Angew. Chem. 100 (1988), 750); this phenomenon has also been observed for polymerized phospholipids (Polymer Sci. 267 (1989), 97-107).
  • n assumes values of 1-m.
  • m assumes values of 0.4-0.6.
  • LB films produced in this way have films which are homogeneous under the light microscope, both on water as subphase and after transfer to a solid support, and are without defects and are particularly suitable for the biosensors according to the invention.
  • Fluorescent dyes which are able to form J-aggregates in LB films have been described in the abovementioned literature. Examples which may be mentioned are cyanine dyes and merocyanines.
  • the functional molecule can be linked covalently, where appropriate using spacer molecules, to the LB film, whether from the start of the spreading process on the water surface onwards or by a subsequent coupling reaction to the LB film either on the subphase or after application of the LB film to a solid support.
  • the functional molecule can be spread together as amphiphile and thus incorporated physically with "anchor" into the LB film.
  • Crucial for the increase in the sensitivity of the sensor system is a highest possible F 1 :F 2 ratio within the "Forster radius" and thus a corresponding enhancement of the fluorescent signal of a molecule labelled with F 2 after binding has taken place to a surface doped with F 1 . Accordingly, it is advantageous to introduce the maximum number of F 1 chromophores into the topmost LB films, especially into the topmost four layers. In a particularly preferred manner, the dye F 1 is located in at least one of the two upper layers.
  • fluorescent dye concentrations below 1% are normally used in fluorescence spectroscopy in order to avoid interactions between the individual dye molecules and thus changes in their fluorescent behaviour, it is nevertheless advantageous in the optical biosensor according to the invention to introduce the fluorescent dye F 1 in high concentrations into the LB films.
  • polymeric amphiphilic fluorescent dyes show less of a tendency to self-quenching and excimer formation at dye concentration of 0.1-25 mol-%.
  • the same concentration range has also proved advantageous in the case where isolated chromophores are to be uniformly distributed in the LB film.
  • Scheibe-aggregates the association of chromophores is desired. This association takes place preferentially at dye concentrations above 25 mol-% up to 100 mol-% (without polymeric matrix).
  • the optical biosensor according to the invention additionally has the advantage that, irrespective of the functional molecules introduced into the films of the solid phase, the dye F 1 which is required for the principle of energy transfer can be introduced into the LB film freely selectably in wide spectral ranges.
  • the functional molecule does not have to be specifically labelled with F 1 and, on the other hand, the spectral range of F 1 can be adjusted to be optimal for an energy transfer to the dye F 2 which is used as marker. Examples of pairs are:
  • the increase in the sensitivity of fluorescence-spectroscopic detection in the optical biosensor according to the invention is achieved, as described, by introducing a maximum possible dye concentration F 1 into the LB film and thus several molecules F 1 achieving the "Forster radius" which is necessary for the energy transfer to a molecule F 2 bound to the film.
  • This construction to introduce a maximum possible dye density F 1 in the LB film system besides the receptor, permits, in contrast to the detection methods based on energy transfer hitherto known, a much more favourable exploitation of this measurement principle and thus a distinctly increased sensitivity because a much larger number of dye molecules can be present per receptor molecule than in the case of a direct fluorescent labelling of the receptor molecule.
  • the donor dye F 1 and the abovementioned active sites for binding of a biomolecule can, in this connection, also be located in different LB films which are arranged in sequence.
  • the total number of LB films effective for the sensor principle varies within the numerical range from 1 to 10.
  • the optical biosensor according to the invention also includes mobile, fluorescent molecules which contain the dye component F 2 and which are reversibly bound to the receptor molecules anchored firmly in the LB film. Only in the simplest case, namely the determination of a self-fluorescent analyte, which thus acts as F 2 , is this component unnecessary because F 2 and ligand are identical and represent the analyte. On the one hand, the binding sites of the receptors on the LB film can be saturated by fluorescent-labelled derivatives or analogues of the analyte molecule, and these can then be displaced competitively by the analyte on contact with the sample solution.
  • sandwich immunoassay in which a second type of receptors, for example antibodies, bind either to the complex between the first receptor and the analyte or to a molecular region on the analyte which is not involved in the binding to the first receptor.
  • a slide made of float glass was cleaned by treatment with H 2 O 2 /H 2 SO 4 and immersed to a depth of 30 mm in the aqueous subphase of a Langmuir film balance (KSV 2200) at 20° C.
  • 150 ⁇ l of a solution of the compound of the formula (IIa) in chloroform (1 mg/ml) were spread on the water surface.
  • three monomolecular layers of polymer were transferred onto the slide by successive emergence and immersion (speed of dipping: 10 mm/min). In this connection, the final film was transferred on emergence.
  • the support was subsequently dried in the air.
  • the dye film was removed from one side of the support by cleaning with chloroform.
  • a film element produced as in Example 4 was dipped in a solution of 10 -7 mol/1 fluorescein in phosphate buffer, pH 7.0, for 5 min. A fluorescent spectrum was recorded before and after the experiment. The emission spectrum shifted towards the maximum of fluorescein.
  • a monomolecular film on water was generated by spreading a solution which contains (VII), methyl arachidate, arachic acid and hexadecane in the molar ratio 1:2:18:20 in chloroform.
  • a monomolecular film on water was generated by spreading a solution of (VII) and hexadecane in the molar ratio 1:1 in chloroform.
  • the following construction of the film element is identical for monomer and Scheibe-aggregates.
  • the film was transferred to the support by contacting the support virtually horizontally with the monofilm.
  • the support was then completely immersed in the water, the remaining film of dye was removed, and a monofilm of stearic acid was formed by spreading a 10 -3 M solution in chloroform and compression to 20 mN/m.
  • the support was then covered with a film of stearic acid by vertical emergence.
  • the support was coated with a mixed film of dioctadecyldimethyl-ammonium bromide and methyl stearate in the molar ratio 1:1 by virtually horizontal contacting and complete immersion of the support, and assembled under water with a cuvette element to give a fluorescence cuvette in a manner known to the skilled worker (see P. Fromherz, Biochim. Biophys. Acta. 323 (1973) 326-334).
  • the binding of the dye to the surface of the film element results in the fluorescence intensity of (VII) being reduced in the case of the Scheibe-aggregates as a function of the concentration of the analyte in the adjoining solution and the time after setting up contact.
  • the binding of the analyte (VIII) to the surface of the film element can also be detected by measuring the fluorescence of (VIII) at 510 nm.
  • Direct excitation emission of the analyte
  • the excitation of (VII) and subsequent energy transfer leads to a maximum emission of the analyte when it takes place at 366 nm (monomer) or 402 nm (Scheibe-aggregates).
  • the ratio of the fluorescence intensities at 510 nm after indirect excitation and energy transfer (I VII ) and on direct excitation of the bound analyte (I VIII ) is the enhancement factor and can be determined from the excitation spectrum of the emission at 510 nm. The following are found for
  • a 50 ⁇ l-drop of a solution of lectin concanavalin A (1 mg/ml) labelled with tetramethylrhodamine isothiocyanate (TRITC) was placed on a film element produced as in Example 4, and a second, untreated slide of the same size was pressed on in such a way that the liquid was distributed uniformly and without air bubbles on the Langmuir-Blodgett (LB) film. After an exposure time of one hour, the two supports were separated and the coated one was washed three times with aqueous phosphate buffer, 10 mmol/l, pH 6.8. A fluorescence spectrum was then recorded and compared with that of a film element not treated with protein. An additional band of the TRITC emission was detected. When two to six dye-free layers were applied on top of the dye-containing LB film, the intensity of this band decreases as a function of the film thickness as far as zero.
  • TRITC tetramethylrhodamine isothiocyan
  • a film element (donor dye) produced as in Example 4 was additionally coated first with two layers of the polymer (V) and then when one layer of the polymer (V) to which a defined amount of an amphiphilic acceptor dye is added. The fluorescence was measured on this film element. The amount of acceptor dye was varied in order to establish the limiting concentration at which the fluorescence of this substance was still just detectable. The following table presents these values for various systems:
  • a film element was prepared by transferring a mixed monolayer consisting of compound (IIa) and succinimidyl stearate (95:5 w/w). On top of this a solution of unlabelled Concanavalin A (1 mg/ml, dissolved in 0.01 mol/l phosphate buffer pH 6.8 containing 1 mmol/l CaCl 2 , 1 mmol/l MnCl 2 and 0.01% Triton X-100) was incubated for 1 hour at room temperature (see Example 6).

Abstract

The present invention relates to a sensor with a novel construction for a detection method of molecules labelled with fluorescent dye for detecting these dissolved substances or analytes by energy transfer with a simple fluorescence technique and increased sensitivity in the detection as well as versatile use for different tasks and the possibility of reproducible preparation of films bound to solid surfaces.

Description

BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to an optical biosensor with a novel construction for a detection method for molecules which are labelled with a fluorescent dye for the detection of dissolved substances or dissolved analytes which behave, for example, like antigen and antibody. This takes the form of a solid-phase sensor with fluorescent dye which permits an energy-transfer process to a molecule which is to be detected and is labelled with a second fluorescent dye.
2. Description of the Related Art
There are various methods for detecting analytes such as hormones, enzymes, other proteins, carbohydrates, nucleic acids, pharmacological active compounds, toxins and others in liquid samples of biological origin. Among the known methods, immunoassays in particular are outstanding as a sensitive detection method for the determination of very small amounts of organic substances. Immunoassay methods are generally based on the ability of a receptor molecule, for example of an antibody, to recognise specifically the structure and molecular organization of a ligand molecule, whether it is defined by non-polar and/or polar interactions, and to bind this molecule very specifically in such a manner.
Immunoassays are carried out by various methods. These include the use of various labelling techniques, usually of a radioactive, enzyme-coupled and fluorescent nature too (Methods in Enzymology, 74 (1981), 28-60) .
Some of these known immunoassay methods entail the use of fluorescent dye molecules F1 which are able to absorb light of a wavelength λ1 and to emit light of a second, larger wavelength λ2. Under certain conditions, in the presence of another fluorescent dye molecule F2, excitation of F1 by light of the wavelength λ1 is followed by a radiationless energy transfer to F2 which then in turn emits light of a third, even larger wavelength λ3.
This principle of energy transfer has been described in theory by Fo rester and has been the stimulus for a wide variety of possible applications (Annual Reviews in Biochemistry 47 (1978), 819-846). One important property of this energy transfer is its dependence on distance. The efficiency of energy transfer according to Fo rster is described by the critical radius Ro, namely the distance between donor and acceptor at which the intermolecular energy transfer is of equal probability to the total of all other inactivating processes of the donor. This distance is about 50-100 Å.
Immunoassays which are based on exploitation of the distance-dependent energy transfer have already been described. Thus, EP 150,905 describes an immunoassay operating in homogeneous solution, in which analyte or antigen has been labelled with a fluorescent dye F1 and the antibody which binds specifically thereto has been provided with a fluorescent dye F2. In order to detect the specific binding, and thus as analytical method, use is made of the fact that when light of wavelength λ1 is passed in, emission of the wavelength λ3 can be observed only if analyte and antibody are present in sufficient concentration at a distance which is sufficiently small for energy transfer according to Fo rester. This is the case only when analyte and antibody have entered into specific binding.
In another example, one of the two labelled binding partners is attached to a solid surface, and the correspondingly specifically binding partner is bound from a homogeneous solution. Once again the specific binding is detected as already explained above by an appropriate energy transfer by means of evanescent wave technology (Nature 320 (1986), 179-181).
Both the energy transfer in homogeneous solution, which is mentioned here, and the described solid-phase immunoassay with energy transfer have the disadvantage in principle that the molecules which bind specifically with one another have in each case to be labelled with one of the two necessary fluorescent dyes F1 and F2 and, according to Nature 320 (1986), 179-181, allow a maximum F1 :F2 ratio of 2:1.
Methods with which the sensitivity, which is limited by the ratio of the two fluorescent dyes F1 and F2, of the fluorescent-spectroscopic detection can be improved have already been described. Thus, it is proposed in EP 174,744 that several organic dye molecules be covalently bonded simultaneously to one "light-collecting" protein, that is to say energy transfer of several organic dye molecules to only one acceptor molecule takes place, namely a phycobiliprotein (allophycocyanin) in EP 174,744. This molecular system is then in turn proposed as a "marker" for other biological molecules. The method is limited by the dye:protein coupling ratio.
A further disadvantage of the stated systems derives from the fact that complementary systems have in each case to be specifically labelled and thus versatile use is impossible. Another disadvantage of these systems constructed in heterogeneous phase is the specific evanescent wave technique used. Moreover, the immobilization of the specifically binding molecules to the solid surface via a coupling component/antibody/antigen/antibody system entails very elaborate preparation. Another disadvantage in principle of this solid-phase technology in immunoassays is the reproducible preparation of coatings of the assay matrix with the reactants in the immune reaction. However, besides sensitivity and selectivity for a target substance, an essential quality feature for analytical methods is the reproducibility of the detection method.
SUMMARY OF THE INVENTION
The present invention relates to a sensor with a novel construction for a detection method of molecules labelled with fluorescent dye for detecting these dissolved substances or analytes by energy transfer with a simple fluorescence technique and increased sensitivity in the detection as well as versatile use for different tasks and the possibility of reproducible preparation of films bound to solid surfaces. Besides the distinct increase in sensitivity, all the disadvantages listed above are simultaneously avoided.
The invention relates to an optical biosensor based on fluorescence energy transfer, consisting of
a) a solid support,
b) a single-layer or multilayer Langmuir-Blodgett (LB) film attached to a),
c) at least one fluorescent dye F1 which is located in at least one of the top 4 layers of the LB film,
d) a receptor molecule which is capable of specific interaction and which is bound or located in or on the topmost layer of the LB film, and
e) a mobile fluorescent dye F2 whose excitation band overlaps, sufficiently for an energy transfer, with the emission band of F1 and which
e1) is covalently bonded to a ligand which is able to bind to the receptor, or which
e2) is covalently bonded to another receptor which is able to bind to the complex composed of the first receptor and ligand,
where the ligand or the ligand and the second receptor are initially not bound to the LB film.
BRIEF DESCRIPTION OF THE DRAWING
FIG. 1 is a schematic representation of the optical biosensor of the present invention.
DETAILED DESCRIPTION OF THE INVENTION
Suitable supports are all supports which are known to the skilled worker and are suitable for the LB technique, such as glass, quartz glass, other glasses such as Li niobate, zinc selenide, porcelain, semiconductor materials such as germanium, GaAs or silicon, and metals.
Also suitable are: plastics such as polymethylmethacrylate, polycarbonate, polystyrene and others, and metallized plastics. The solid support materials can also be surface-modified before the coating, for example glass or quartz or silicon by pretreatment with trichloromethylsilane, dichlorodimethylsilane, trichlorooctadecylsilane, hexamethyldisilazane or by plasma etching or plasma polymerization. In a preferred manner, the supports take the form of optionally surface-modified glass, quartz glass, silicon, plastic or a metallized plastic. Other preferred supports are optically transparent. All support materials are additionally distinguished by a uniform surface, preferably by a plane surface.
One or more monomolecular films are applied to such supports with the aid of the LB technique. The LB technique means hereinafter a process for transferring monomolecular films from a liquid (water) surface to a solid support by the Langmuir-Blodgett process. For this, a solid support with an essentially smooth surface is dipped in a manner known per se through a compressed monomolecular film on the liquid surface and, in this way, this film is transferred to the support.
It is possible in this way to prepare multilayer systems by multiple immersion and emergence. The film on the liquid surface can be replaced after each dipping procedure so that different sequences of films can be prepared on the support.
The immersion and emergence can take place at right angles or obliquely to the liquid surface. Furthermore, it is possible according to the Langmuir-Schafer technique for the support also to be contacted at a point or at an edge with the liquid surface and then pivoted onto the liquid surface. Finally, the support can also be lowered onto the liquid surface in a parallel manner ("horizontal dipping").
The transfer takes place at a temperature of 5°-40° C., preferably at room temperature.
These ordered LB films can consist of low molecular weight and/or polymeric amphiphiles, preferably of polymeric amphiphiles, and can contain covalently bonded fluorescent chromophore/dyes and/or amphiphilic fluorescent chromophore/dyes, which are called F1 hereinafter.
These LB films additionally contain or are covalently linked to functional molecules as receptors, for example glycolipids, poly- and oligonucleotides, proteins or fragments thereof, haptens and others. It is now possible for a specific binding to these receptors to take place by a molecule complementary thereto (ligand), such as by a lectin, an antigen, an antibody and others, which is labelled with a second fluorescent dye F2 appropriate for energy transfer with F1. In the case of binding between receptor and ligand, the so-called Fo rster distance between F1 and F2, as is necessary for the energy transfer described above, ought to be complied with. This condition is ensured by the use of the LB technique which allows a specific molecular architecture, especially in dimensions of the range of interest here, of about 10-100 Å. If the system described hereinbefore is now excited with light of the wavelength λ1, it is possible to detect an emission of the fluorescent dye F2 with a wavelength λ3, which is regarded as demonstrating the binding of the molecule labelled with F.sub. 2 to the sensor surface which is doped with F1. Excitation with light of the wavelength λ1 can be carried out in such a way that F1 in the LB film is excited by transmission through the optically transparent support or by evanescent wave technique, when the optically transparent support acts as light guide, or else by incident irradiation.
The specific interaction between 2 molecules which are complementary to one another is known to the skilled worker in the field of biologically, bio-chemically and, very particularly, medically (physio-logically) important molecules, for example of the abovementioned type. Such interactions derive in the final analysis from ionic linkages, hydrogen bonds and van der Waals forces, which are, however, effective in the area of the abovementioned molecules only with specific spatial (steric) circumstances (lock and key theory). It is, of course, also possible to use the optical biosensor according to the invention for detecting specific interactions without such specific spatial circumstances; this use is particularly important for checking the reliability of functioning, the accuracy of measurement and other properties of the optical biosensor according to the invention.
The sensor construction described in this way is able in this function to detect not only an analyte present in solution and labelled with a fluorescent dye F2 ; the sensor construction can also be used to detect in a competitive mode of functioning an analyte which is not fluorescent-labelled. For this purpose, when preparing the sensor, the specific binding sites of the functional molecules in the LB film are saturated with fluorescent-labelled molecules which bind complementarily. Then, on excitation with light of the wavelength λ1 there is observed a maximum fluorescence emission of the wavelength λ3, whose decrease over a time course can be observed when, on contact with the solution to be investigated, the molecules which are fluorescent-labelled with F2 and bind complementarily are displaced in an equilibrium reaction by molecules of the same type which are not fluorescent-labelled and bind complementarily.
Amphiphilic molecules, that is to say molecules which have a hydrophilic end (a "head") and a hydrophobic end (a "tail") are used for constructing LB films. Such amphiphilic molecules can be low-molecular weight compounds with a molecular weight of up to about 2000 g/mol. In another variant, these low molecular weight amphiphiles can contain functional groups which are capable of polymerization or capable of polycondensation and polyaddition so that, after construction of the LB films from low molecular weight amphiphiles, these amphiphiles in the LB film can be linked in a subsequent reaction to give high molecular weight compounds. This subsequent reaction to give high molecular weight compounds is advantageous because LB films composed of polymeric amphiphiles have higher thermal and mechanical stabilities.
It is possible particularly elegantly to prepare LB films from amphiphilic polymers by bringing about the linkage of the amphiphilic units before the latter are spread in a known manner on the liquid surface to give monomolecular films. The use of such prepolymerized amphiphilic polymers thus avoids possible disturbance, by subsequent polymerization in the LB film, of the ordered state once it has been produced.
Examples of polymeric amphiphiles as are suitable for the optical biosensor according to the invention are a-olefin/maleic anhydride copolymers (British Polymer Journal 17 (1985), 368 et seq.; J. Macromol. Sci. Phys. B 23 (1985), 549-573), polyoctadecylmethacrylate, polyvinyl stearate (J. Coll. Interface Sci. 86 (1982), 485), polyvinylphospholipids (Angew. Chem. 100 (1988), 117-162), cellulose tristearate, amphiphilic polyamides (DE-OS (German Published Specification) 3,830,325) and acrylamide copolymers. Suitable and preferred for the preparation of stable LB films are polyurethanes according to DE-OS (German Published Specification) 3,827,438 and polyesters according to DE-OS (German Published Specification) 3,830,862. Among the polymeric amphiphiles, reference may also be made very especially to random poly(alkyl methacrylate) copolymers of the following type, whose composition can vary widely: ##STR1## in which R1, R2 and R3 represent, independently of one another, hydrogen or methyl,
R4 is straight-chain C14 -C22 -alkyl,
R5 is the hydrogen, sodium or potassium ion or represents one of the groups --CH2 --CH2 OH, --CH2 --CH2 --NH-tertbutyl, --CH2 --CH2 --N(CH3)2, ##STR2## R6 is a fluorescent chromophore which is known to the skilled worker and is represented hereinafter, and
x assumes a value of 0.2-1,
y assumes a value of 0-0.8 and
z assumes a value of 0-0.2, where the total x+y+z=1.
In a preferred manner, x and y are approximately equal.
Examples of polymers of the formula (I) are the following: ##STR3##
In the case of the substances mentioned here by way of example for LB mono- and -multifilms, the fluorescent chromophore is covalently linked to the amphiphilic polymer. Although this arrangement allows the maximum possible stability of the F1 -containing LB films, it is also possible, however, to obtain F1 -containing LB films by spreading an amphiphilic polymer together with amphiphilic fluorescent dyes on the water surface before the coating process. Examples of such amphiphilic fluorescent dyes which can be used together with amphiphilic polymers which contain no chromophores are, for example, cyanine dyes of the types ##STR4## in which X and Y represent, independently of one another, oxygen, sulphur or selenium or C(CH3)2,
R7 denotes hydrogen or methyl, and
R8 and R9 represent, independently of one another, straight-chain C1 -C22 -alkyl.
Further examples of fluorescent dyes which are known in principle to the skilled worker and can be used according to the invention are dyes of the following types: ##STR5##
This list is only by way of example. Further amphiphilic fluorescent dyes are described in the monograph Physical Methods of Chemistry, Vol. 1, Part. 3B, pages 577 et seq., John Wiley, New York 1972. If the intention is to introduce such amphiphilic fluorescent dyes into LB films, care must be taken that there is uniform distribution of the dye throughout the film. Thus, it is necessary to avoid the transfer of individual films taking place, depending on the temperature (typically 5°-40°, preferably about 20° C.), with such an applied thrust at which a coexistence region of the solid-analogous and liquid-analogous phase is passed through. This is important because the amphiphilic fluorescent dye does not, as a rule, have the same solubility in both phases and thus inhomogeneous films, which are less suitable for the sensor application, are formed. This phenomenon is known for LB films composed of low molecular weight substances (Angew. Chem. 100 (1988), 750); this phenomenon has also been observed for polymerized phospholipids (Polymer Sci. 267 (1989), 97-107).
It has been found in the production of optical biosensors according to the invention, surprisingly, that LB films composed of polymers of the formula (II) do not tend to form phase-separated domains when thrusts are applied up to collapse of the LB film at >45 mN/m thrust. Besides polymers of the formula (II), this also applies to a mixture of a polymer of the type of the formula (V) and of a dye, for example of the formula (IVa), where the polymer of the type of the formula (V) is to be regarded as "matrix" in which 0.1 to 25 mol-% of the amphiphilic dye can be accommodated, where the repeat units are used for calculating the molar percentages in the polymer: ##STR6## in which m assumes values of 0.25-1 and
n assumes values of 1-m.
In a preferred manner, m assumes values of 0.4-0.6.
LB films produced in this way have films which are homogeneous under the light microscope, both on water as subphase and after transfer to a solid support, and are without defects and are particularly suitable for the biosensors according to the invention.
However, in the case of systems with phase-separated domains, it is also possible to achieve a high sensitivity of the optical biosensor according to the invention when fluorescent dyes F1 are used as donor in LB films which, by reason of their specific behaviour, form aggregates with fluorescent-spectroscopic properties which differ greatly from those of the monomeric dye and which, as a rule, are distinguished by a correspondingly sharper and more intense absorption band and correspondingly sharper and more intense fluorescence emission band. Aggregates of this type are known to the skilled worker as J-aggregates or Scheibe-aggregates (Physical Methods of Chemistry, Vol. 1, Part. 3B, page 579, John Wiley, New York 1972). With the specific behaviour of such J aggregates, it is possible on the one hand to achieve a very high dye density F1 in the LB films, and on the other hand to achieve, by reason of the strong absorption of light of the wavelength λ1, a high energy density which, according to the theory of Forster, can be transferred to appropriate molecules F2. The small half-width of the emission band means both an amplifying effect on the measured signal and a reduction in the interfering radiation owing to less overlap of the emissions of F1 with F2.
Fluorescent dyes which are able to form J-aggregates in LB films have been described in the abovementioned literature. Examples which may be mentioned are cyanine dyes and merocyanines.
The incorporation of functional molecules into the LB film containing the fluorescent dye F1 can be carried out in a variety of ways:
The functional molecule can be linked covalently, where appropriate using spacer molecules, to the LB film, whether from the start of the spreading process on the water surface onwards or by a subsequent coupling reaction to the LB film either on the subphase or after application of the LB film to a solid support.
The functional molecule can be spread together as amphiphile and thus incorporated physically with "anchor" into the LB film.
Methods are known from the literature for both incorporation variants. For example, the linkage of biological functional groups to LB films on solid supports can be carried out in a manner analogous to the immobilization methods known to the skilled worker from biochemistry (Methods in Enzymology, Vol. 135 and Vol. 136 (1987)). A large selection of molecules provided with long alkyl chains is mentioned in DE-OS (German Published Specification) 3,546,150 as membrane anchor-active compound conjugates, and they can be incorporated into the LB film by spreading together on the subphase. Glycolipids, for example ceramides, may be mentioned as an example of such amphiphilic functional molecules. Other examples are antibody/antigen systems as well as complementary nucleotide sequences. A large number of such examples is known to the skilled worker (Angew. Chem. 100 (1988), 117-162).
Crucial for the increase in the sensitivity of the sensor system is a highest possible F1 :F2 ratio within the "Forster radius" and thus a corresponding enhancement of the fluorescent signal of a molecule labelled with F2 after binding has taken place to a surface doped with F1. Accordingly, it is advantageous to introduce the maximum number of F1 chromophores into the topmost LB films, especially into the topmost four layers. In a particularly preferred manner, the dye F1 is located in at least one of the two upper layers.
Although fluorescent dye concentrations below 1% are normally used in fluorescence spectroscopy in order to avoid interactions between the individual dye molecules and thus changes in their fluorescent behaviour, it is nevertheless advantageous in the optical biosensor according to the invention to introduce the fluorescent dye F1 in high concentrations into the LB films. In particular, polymeric amphiphilic fluorescent dyes show less of a tendency to self-quenching and excimer formation at dye concentration of 0.1-25 mol-%. The same concentration range has also proved advantageous in the case where isolated chromophores are to be uniformly distributed in the LB film. On the other hand, in the particular case of Scheibe-aggregates the association of chromophores is desired. This association takes place preferentially at dye concentrations above 25 mol-% up to 100 mol-% (without polymeric matrix).
The optical biosensor according to the invention additionally has the advantage that, irrespective of the functional molecules introduced into the films of the solid phase, the dye F1 which is required for the principle of energy transfer can be introduced into the LB film freely selectably in wide spectral ranges. This means that, on the one hand, the functional molecule does not have to be specifically labelled with F1 and, on the other hand, the spectral range of F1 can be adjusted to be optimal for an energy transfer to the dye F2 which is used as marker. Examples of pairs are:
______________________________________                                    
F.sub.1                F.sub.2                                            
______________________________________                                    
a)    Polymer (IIa)        TRITC                                          
b)    Cyanine (IIIb) with  TRITC or FITC                                  
      X = Y = O, R.sup.7 = H,                                             
      R.sup.8 = R.sup.9 = C.sub.18 H.sub.37                               
c)    Cyanine (IIIa) with  FITC or TRITC                                  
      X = Se, Y = S,                                                      
      R.sup.7 = CH.sub.3, R.sup.8 = R.sup.9 = C.sub.18 H.sub.37           
______________________________________                                    
 TRITC = tetramethylrhodamine isothiocyanate                              
 FITC = fluorescein isothiocyanate.                                       
The increase in the sensitivity of fluorescence-spectroscopic detection in the optical biosensor according to the invention is achieved, as described, by introducing a maximum possible dye concentration F1 into the LB film and thus several molecules F1 achieving the "Forster radius" which is necessary for the energy transfer to a molecule F2 bound to the film. This construction, to introduce a maximum possible dye density F1 in the LB film system besides the receptor, permits, in contrast to the detection methods based on energy transfer hitherto known, a much more favourable exploitation of this measurement principle and thus a distinctly increased sensitivity because a much larger number of dye molecules can be present per receptor molecule than in the case of a direct fluorescent labelling of the receptor molecule.
Another consequence of the use of all the dye molecules F1 lying within the Forster radius of F2 is that not only the lateral distribution of F1 within the topmost LB films but also the concentration of F1 in the underlying films is of crucial importance. For this reason, the measurement principle is restricted to films with an effective film thickness of up to about 100 Å, because underlying molecules F1 are no longer able, after excitation by light, to transfer their energy to a sufficient extent to the dye F2, which is then too far away, and would predominantly interfere with the signal to be detected, namely the light emission of wavelength λ3 of the dye F2 excited by transfer, owing to their own fluorescence with the wavelength λ2, and unnecessarily reduce the sensitivity of detection.
For this reason, only LB film technology and chemisorption are suitable for producing thin films (100 Å or below) which contain F1. This is because even the method of spin-coating which is widely used in thin-film technology involves problems with minimum film thicknesses of 200 to 500 Å. Compared with the application of thin films by chemisorption, the LB technique has the advantage that the composition of the films can be adjusted in a very defined manner, which is of crucial importance for producing reproducible surfaces for sensors.
The donor dye F1 and the abovementioned active sites for binding of a biomolecule can, in this connection, also be located in different LB films which are arranged in sequence. The total number of LB films effective for the sensor principle varies within the numerical range from 1 to 10.
The optical biosensor according to the invention also includes mobile, fluorescent molecules which contain the dye component F2 and which are reversibly bound to the receptor molecules anchored firmly in the LB film. Only in the simplest case, namely the determination of a self-fluorescent analyte, which thus acts as F2, is this component unnecessary because F2 and ligand are identical and represent the analyte. On the one hand, the binding sites of the receptors on the LB film can be saturated by fluorescent-labelled derivatives or analogues of the analyte molecule, and these can then be displaced competitively by the analyte on contact with the sample solution. On the other hand, however, also possible is a sandwich immunoassay in which a second type of receptors, for example antibodies, bind either to the complex between the first receptor and the analyte or to a molecular region on the analyte which is not involved in the binding to the first receptor. These methods of solid-phase immunoassays are in principle state of the art and described, for example, in the monograph P. Tijssen, Practice and Theory of Enzyme Immunoassays (R. H. Burdon, Ph. H. van Knippenberg, editors) Elsevier, Amsterdam 1985.
EXAMPLE 1 Preparation of an Amphiphilic Fluorescent Dye
1.51 g (5 mmol) of octadecane acid chloride in 5 ml of dry chloroform were added dropwise to 1.53 g (5 mmol) of 7-diethylamino-3-(p-aminophenyl)coumarin and 0.61 g (5 mmol) of triethylamine in 10 ml of dry chloroform while cooling in an ice bath. The mixture was then stirred at 0°-5° C. for one hour and at room temperature for 5 hours. The mixture was washed first with dilute sodium hydroxide solution and finally with water. The crude product was precipitated twice from chloroform with petroleum ether 60°/70° C. ##STR7##
64% of the theoretical yield of the product of the above formula with a melting point of 159° C. were obtained.
1 H-NMR (CDCl3, int. TMS): δ=7.66-6.52 (multiplet, aromatic protons); 3.42 (--CH2 CH3); 2.35 (--COCH2 C16 H33); 1.22 (--CH2 CH3); 1.7-0.8 (--COCH2 C16 H33).
Compounds IVb to IVi which are listed hereinbefore were also prepared in an analogous manner. Some spectroscopic data are compiled in Tab. 1.
              TABLE 1                                                     
______________________________________                                    
Spectroscopic data on amphiphilic dyes                                    
       Spectroscopic data in CH.sub.2 Cl.sub.2                            
         Exc..sub.max  Em..sub.max                                        
                               Δ Stokes                             
Formula  λ (nm) λ (nm)                                      
                               (nm)                                       
______________________________________                                    
IVa      406           476     70                                         
IVe      528           549     21                                         
IVf      475           511     36                                         
IVg      531           585     54                                         
IVh      460           495     35                                         
IVi      368           452     84                                         
______________________________________                                    
EXAMPLE 2 Preparation of a Polymerizable Fluorescent Dye
0.52 g (5 mmol) of methacryloyl chloride in 5 ml of dry chloroform was added dropwise to 1.53 g (5 mmol) of 7-diethylamino-3-(p-aminophenyl)coumarin and 0.61 g (5 mmol) of triethylamine in 10 ml of dry chloroform while cooling in an ice bath. The mixture was then stirred at 0°-5° C. for one hour and at room temperature for 5 hours. The mixture was washed first with sodium hydroxide solution and finally with water until free of salts and was concentrated to dryness. Yield: 1.6 g corresponding to a theoretical yield of 86% of the product of the formula VIa, which is detailed below (Tab. 2), with a melting point of 193°-195° C.
1 H-NMR (CDCl3, int. TMS): δ=9.43 (NH), 7.77-6.49 (multiplet, arom. protons); 5.86 and 5.47 (H2 C═); 3.44 (--CH2 CH3); 2.04 (═C--CH3); 1.22 (--CH2 CH3).
The compounds VIb to VIf which are likewise listed in Tab. 2 were also prepared in an analogous manner. Some spectroscoic data are compiled in Tab. 2.
                                  TABLE 2                                 
__________________________________________________________________________
Spectroscopic data on polymerizable fluorescent dyes                      
                                  Spectroscopic data in                   
                                  CH.sub.2 Cl.sub.2                       
                                  Exc..sub.max.                           
                                       Em..sub.max.                       
                                            ΔStokes                 
Formula                           λ (nm)                           
                                       λ (nm)                      
                                            (nm)                          
__________________________________________________________________________
 ##STR8##                         395  475  80                            
 ##STR9##                         401  475  74                            
 ##STR10##                        382  491  110                           
 ##STR11##                        456  507  51                            
 ##STR12##                        528  546  17                            
 ##STR13##                        450  496  46                            
__________________________________________________________________________
EXAMPLE 3 Preparation of a Polymer Containing a Fluorescent Dye
6.77 g (20 mmol) of octadecyl methacrylate, 4.00 g (20 mmol) of (2,2-dimethyl-1,3-dioxolan-4-yl)-methylenemethacrylate and 1.51 g (4 mmol) of the dye monomer of Example 2 were dissolved in 90 ml of absolute dioxane and, after addition of 1.44 g (0.2 mol-%) of azobis(isobutyronitrile), heated while stirring to 65°-70° C. and kept at this temperature for 16 hours. After cooling, the polymer was precipitated from the reaction solution by introducing it into water. The polymer was purified by dissolving in chloroform and precipitating in methanol twice.
3.93 g of a yellowish green polymer were obtained and were characterized by gel permeation chromatography in CH2 Cl2. Simultaneous detection of refractive index and UV spectroscopy provided identical molecular weight distribution curves so that uniform incorporation of the fluorescent dye in the polymer was ensured. The molecular mass values calculated by comparison with a polystyrene standard were Mn =64,000 and Mw =1,290,000, corresponding to a non-uniformity of 18.1.
All the methacrylate copolymers were prepared by this general preparative procedure.
EXAMPLE 4 Preparation of a Film Element Containing Fluorescent Dye
a) Polymeric dye
A slide made of float glass was cleaned by treatment with H2 O2 /H2 SO4 and immersed to a depth of 30 mm in the aqueous subphase of a Langmuir film balance (KSV 2200) at 20° C. 150 μl of a solution of the compound of the formula (IIa) in chloroform (1 mg/ml) were spread on the water surface. After the film had been compressed to a surface pressure of 25 mN/m, three monomolecular layers of polymer were transferred onto the slide by successive emergence and immersion (speed of dipping: 10 mm/min). In this connection, the final film was transferred on emergence. The support was subsequently dried in the air. The dye film was removed from one side of the support by cleaning with chloroform.
b) Polymer containing dispersed monomeric dye
Used in place of the solution of the dye-containing polymer of the formula (IIa) was a mixture of the polymer of the formula (V), 1 mg/ml, and of the monomeric amphiphilic dye of the formula (IIb) with X=Y=O, n=18, R7 =H, R8 =R9 =C18 H37, 1 mg/ml, in the ratio 19:1.
c) Polymer containing dispersed dye which forms Scheibe-aggregates
A mixture of the polymer of the formula (V), 1 mg/ml, and of the dye of the formula (IIIb), with X=Se, Y=S, R8 =R9 =C18 H37, R2 =CH3, 1 mg/ml, in the ratio of 1:1 by weight, was picked up.
EXAMPLE 5a Adsorption of Fluorescent Dyes onto a Film Element and Observation of Fluorescent Energy Transfer
A film element produced as in Example 4 was dipped in a solution of 10-7 mol/1 fluorescein in phosphate buffer, pH 7.0, for 5 min. A fluorescent spectrum was recorded before and after the experiment. The emission spectrum shifted towards the maximum of fluorescein.
EXAMPLE 5b Production of a Film Element Containing Fluorescent Dye
A glass support which had been cleaned by ultrasonic treatment in an aqueous detergent solution and subsequently rinsed by ultrasonic treatment with pure water and further ultrasonic treatment (5 min) in approx. 5×10-2 N NaOH and by spraying with pure water under a pressure of 5 atm, and had then been dried, was rendered hydrophobic by exposure to hexamethyldisilazane in a desiccator (30 min at 60° C. under water pump vacuum). After this treatment, the glass support was briefly dipped in water and, after removal from the water, its surface was carefully sucked off. Two films of cadmium arachidate were transferred onto this support by the LB technique by immersion and emergence of the support.
The subsequent film of fluorescent dye (VII)=(IIIa) with X=Y=O, R7 =H, R8 =R9 =C18 H37 was prepared and transferred in different organisation, i) as monomer of the dye and ii) as Scheibe-aggregates (J-aggregates) of the dye.
i) Monomer of the dye (VII)
A monomolecular film on water was generated by spreading a solution which contains (VII), methyl arachidate, arachic acid and hexadecane in the molar ratio 1:2:18:20 in chloroform.
ii) Scheibe-aggregates of the dye (VII)
A monomolecular film on water was generated by spreading a solution of (VII) and hexadecane in the molar ratio 1:1 in chloroform.
The following construction of the film element is identical for monomer and Scheibe-aggregates. After compression of the film to a thrust of 20 mN/m and storage for 10 min at constant thrust, the film was transferred to the support by contacting the support virtually horizontally with the monofilm. The support was then completely immersed in the water, the remaining film of dye was removed, and a monofilm of stearic acid was formed by spreading a 10-3 M solution in chloroform and compression to 20 mN/m. The support was then covered with a film of stearic acid by vertical emergence. Finally, the support was coated with a mixed film of dioctadecyldimethyl-ammonium bromide and methyl stearate in the molar ratio 1:1 by virtually horizontal contacting and complete immersion of the support, and assembled under water with a cuvette element to give a fluorescence cuvette in a manner known to the skilled worker (see P. Fromherz, Biochim. Biophys. Acta. 323 (1973) 326-334).
EXAMPLE 5c
A film element produced as in Example 5b was brought into contact with an aqueous solution of the analyte (VIII) (formula see below) in a 10-4 M phosphate buffer, pH=7.0, by replacing the aqueous medium without exposing the surface of the film element to air. The binding of the dye to the surface of the film element results in the fluorescence intensity of (VII) being reduced in the case of the Scheibe-aggregates as a function of the concentration of the analyte in the adjoining solution and the time after setting up contact. In the case of a 10-7 M solution of (VIII) the intensity of emission at 404 nm and excitation at 366 nm after 90 min is 33% of the intensity in the absence of (VIII), in the case of a 10-10 M solution 85%.
As expected, this quenching effect is observed to depend distinctly on the distance when by incorporation of a double film of cadmium stearate between the stearic acid film which is enlarged in contact with the dye film from the surface of the film element. The intensity of emission from the Scheibe-aggregate at 404 nm for a 10-7 M solution of (VIII) is then 90% of the intensity observed in the absence of (VIII).
The binding of the analyte (VIII) to the surface of the film element can also be detected by measuring the fluorescence of (VIII) at 510 nm. Direct excitation (emission of the analyte) is possible at 470 nm, whereas the excitation of (VII) and subsequent energy transfer leads to a maximum emission of the analyte when it takes place at 366 nm (monomer) or 402 nm (Scheibe-aggregates). The ratio of the fluorescence intensities at 510 nm after indirect excitation and energy transfer (IVII) and on direct excitation of the bound analyte (IVIII) is the enhancement factor and can be determined from the excitation spectrum of the emission at 510 nm. The following are found for
a) Monomers:
IVII /IA =3 for 10-7 M solution of (VIII)
IVII /IA =35 for 10-8 M solution of (VIII)
b) Scheibe-aggregates:
IVII /IA =380 for 10-8 M solution of (VIII) ##STR14##
EXAMPLE 6 Adsorption of Fluorescent-Labelled Protein to a Film Element and Observation of Fluorescence Energy Transfer
A 50 μl-drop of a solution of lectin concanavalin A (1 mg/ml) labelled with tetramethylrhodamine isothiocyanate (TRITC) was placed on a film element produced as in Example 4, and a second, untreated slide of the same size was pressed on in such a way that the liquid was distributed uniformly and without air bubbles on the Langmuir-Blodgett (LB) film. After an exposure time of one hour, the two supports were separated and the coated one was washed three times with aqueous phosphate buffer, 10 mmol/l, pH 6.8. A fluorescence spectrum was then recorded and compared with that of a film element not treated with protein. An additional band of the TRITC emission was detected. When two to six dye-free layers were applied on top of the dye-containing LB film, the intensity of this band decreases as a function of the film thickness as far as zero.
EXAMPLE 7 (FOR COMPARISON) Preparation of Film Elements Using Alternative Techniques
a) Smear technique
50 μl of a solution of the polymer (IIa), 1 mg/ml, in chloroform were placed on a slide. A second slide was used to smear the dye solution as uniformly as possible on the first. 50 μl of TRITC-ConA were then adsorbed, as described in Example 6, on this dye layer, and the fluorescence was measured. Besides the very intense band of (IIa) the fluorescence of TRITC cannot be detected unambiguously.
b) Spin-coating technique
0.0193 to 0.244 mg of the polymer (IIa) was dissolved in 0.25 to 1.5 ml of chloroform or dimethylformamide and put onto a cleaned glass support of 10 cm diameter using a spin-coater. Fluorescence measurements on the resulting glass plates showed a very heterogeneous distribution of dye density so that it was not possible to make any measurements of energy transfer.
EXAMPLE 8 Measurement of the Limiting Sensitivity of the Forster Energy Transfer System
A film element (donor dye) produced as in Example 4 was additionally coated first with two layers of the polymer (V) and then when one layer of the polymer (V) to which a defined amount of an amphiphilic acceptor dye is added. The fluorescence was measured on this film element. The amount of acceptor dye was varied in order to establish the limiting concentration at which the fluorescence of this substance was still just detectable. The following table presents these values for various systems:
______________________________________                                    
                         Limiting concentration                           
Donor dye                                                                 
         Acceptor dye    [10.sup.-15 mol/mm.sup.2 ]                       
______________________________________                                    
from 4a  (C.sub.18 rhodamine)                                             
                         3                                                
from 4b                  0.3                                              
from 4c                  0.3                                              
from 4c  (C.sub.18 aminofluorescein)                                      
                         3                                                
______________________________________                                    
EXAMPLE 9 Specific Binding of a Mannoside to Concanavalin A
In analogy to Example 4 a film element was prepared by transferring a mixed monolayer consisting of compound (IIa) and succinimidyl stearate (95:5 w/w). On top of this a solution of unlabelled Concanavalin A (1 mg/ml, dissolved in 0.01 mol/l phosphate buffer pH 6.8 containing 1 mmol/l CaCl2, 1 mmol/l MnCl2 and 0.01% Triton X-100) was incubated for 1 hour at room temperature (see Example 6). The element was washed with 0.5 ml of the same buffer; 50 μl of a solution (0.1 mg/ml dissolved in the above buffer) of the TRITC-mannoside (IX) were then applied, and the film element was covered up again. As a blank control, an equal amount of bovine serum albumin was used instead of Con A. A comparison of the two film elements' fluorescence spectra showed that when using Con A the rhodamine emission at 580 nm (from IX) is about fivefold stronger than the coumarin emission at 495 nm (from IIa). When using bovine serum albumin there is almost no rhodamine emission (less than 1/20) visible in comparison with a strong coumarin emission. ##STR15##

Claims (12)

What is claimed is:
1. A process for the detection of analyte molecules in a sample comprising providing a sensor consisting of a) a solid support,
b) a single layer or multi-layer Langmuir-Blodgett (LB) film attached to the surface of said support a),
c) at least one fluorescent dye F1 which is located in the top layer or in case of a multi-layer Langmuir-Blodgett film, in at least one of the top four layers of the Langmuir-Blodgett film,
d) a first receptor molecule which is capable of specific binding with said analyte molecule and which is bonded covalently or by absorption in or on the topmost layer of the Langmuir-Blodgett film, and
e) exposing said sensor to said sample and a mobil fluorescent dye F2 whose excitation band overlaps sufficiently for an energy transfer with the emission band of said dye F1 and which
e1) is covalently bonded to a second receptor molecule which competes with said analyte molecules for specifically binding to said first receptor molecule d) or which
e2) is covalently bonded to a third receptor molecule which is able to bind to a complex composed of the first receptor molecule d) and said analyte molecule,
where the second molecule or the complex of the analyte molecule and the third receptor molecule are initially not bound to the Langmuir-Blodgett film,
and detecting a change in the level of fluorescence energy transfer in response the said exposing step.
2. A sensor for the detection of analyte molecules based on fluorescence energy transfer (Forster transfer) consisting of
a) a solid support,
b) a single layer or multi-layer Langmuir-Blodgett film (LB) attached to the surface of said support a),
c) at least one fluorescent dye F1 which is located in the top layer or in case of a multi-layer Langmuir-Blodgett film, in at least one of the top four layers of the Langmuir-Blodgett film,
d) a receptor molecule which is capable of specific interaction with a ligand molecule and which is bonded covalently or by adsorption in or on the topmost layer of the Langmuir-Blodgett film.
3. A sensor according to claim 2 wherein the solid support used is composed of glass, quartz glass, Li niobate, zinc selenide, porcelain, semi-conductor materials, a metal, a plastic or a metallized plastic.
4. A sensor according to claim 3, wherein the solid support used is composed of glass, quartz glass, silicon, plastic or a metallized plastic.
5. A sensor according to claim 2, wherein the Langmuir-Blodgett film consists of a polymer.
6. A sensor according to claim 5, wherein said dye F1 is covalently bonded to the polymer.
7. A sensor according to claim 2, wherein the dye F1 is spread together with an amphiphilic matrix.
8. A sensor according to claim 2, wherein, in the case of a multi-layer Langmuir-Blodgett film the dye F1 is located in at least one of the two upper layers of the LB film.
9. A sensor according to claim 2, wherein the receptor molecule is attached covalently to the topmost layer of the LB film.
10. The sensor of claim 9, wherein the receptor molecule d) is attached covalently via a spacer molecule to the topmost layer of the LB film.
11. The sensor of claim 2, wherein the receptor molecule d) is located onto the topmost layer of the film via a hydrophobic membrane anchor.
12. Sensor of claim 7 is which the dye F1 forms Scheibe-aggregates.
US07/611,197 1989-11-21 1990-11-08 Optical biosensor and method of use Expired - Lifetime US5194393A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3938598 1989-11-21
DE19893938598 DE3938598A1 (en) 1989-11-21 1989-11-21 Optical bio-sensor - based on fluorescent energy transfer between one dye incorporated in Langmuir-Blodgett film and marker dye
DE19904013713 DE4013713A1 (en) 1990-04-28 1990-04-28 Optical bio-sensor with Langmuir-blodgett film contg. fluorescent dye
DE4013713 1990-04-28

Publications (1)

Publication Number Publication Date
US5194393A true US5194393A (en) 1993-03-16

Family

ID=25887278

Family Applications (1)

Application Number Title Priority Date Filing Date
US07/611,197 Expired - Lifetime US5194393A (en) 1989-11-21 1990-11-08 Optical biosensor and method of use

Country Status (8)

Country Link
US (1) US5194393A (en)
EP (1) EP0429907B1 (en)
JP (1) JPH03176662A (en)
AT (1) ATE106566T1 (en)
CA (1) CA2030244A1 (en)
DE (1) DE59005928D1 (en)
DK (1) DK0429907T3 (en)
FI (1) FI98570C (en)

Cited By (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496522A (en) * 1994-02-07 1996-03-05 Martin Marietta Energy Systems, Inc. Biosensor and chemical sensor probes for calcium and other metal ions
US5512328A (en) * 1992-08-07 1996-04-30 Hitachi, Ltd. Method for forming a pattern and forming a thin film used in pattern formation
US5552272A (en) * 1993-06-10 1996-09-03 Biostar, Inc. Detection of an analyte by fluorescence using a thin film optical device
US5577137A (en) * 1995-02-22 1996-11-19 American Research Corporation Of Virginia Optical chemical sensor and method using same employing a multiplicity of fluorophores contained in the free volume of a polymeric optical waveguide or in pores of a ceramic waveguide
US5591407A (en) * 1995-04-21 1997-01-07 American Research Corporation Of Virginia Laser diode sensor
US5671303A (en) * 1996-04-17 1997-09-23 Motorola, Inc. Molecular detection apparatus and method using optical waveguide detection
US5690894A (en) * 1995-05-23 1997-11-25 The Regents Of The University Of California High density array fabrication and readout method for a fiber optic biosensor
US5711915A (en) * 1992-03-18 1998-01-27 Bayer Aktiengesellschaft Optical solid-phase biosensor based on polyionic layers labelled with fluorescent dyes
US5763189A (en) * 1993-09-24 1998-06-09 Biosite Diagnostics Incorporated Fluorescence energy transfer and intramolecular energy transfer in particles using novel compounds
US5792621A (en) * 1995-06-28 1998-08-11 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Fiber-optic chemiluminescent biosensors for monitoring aqueous alcohols and other water quality parameters
US5824799A (en) * 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
US5837196A (en) * 1996-01-26 1998-11-17 The Regents Of The University Of California High density array fabrication and readout method for a fiber optic biosensor
US5854863A (en) * 1996-03-15 1998-12-29 Erb; Judith Surface treatment and light injection method and apparatus
US5871915A (en) * 1995-03-13 1999-02-16 Research Development Corporation Of Japan Method for detecting nucleic acid polymer
US6051437A (en) * 1998-05-04 2000-04-18 American Research Corporation Of Virginia Optical chemical sensor based on multilayer self-assembled thin film sensors for aquaculture process control
US6103535A (en) * 1996-05-31 2000-08-15 University Of Maryland Optical fiber evanescent field excited fluorosensor and method of manufacture
US6235535B1 (en) * 1996-06-28 2001-05-22 Valtion Teknillinen Tutkimuskeskus Fluorescent energy transfer ligand interaction assay on a lipid film
US6251687B1 (en) 1993-09-24 2001-06-26 Biosite Diagnostics, Inc. Fluorescence energy transfer and intramolecular energy transfer in particles using novel compounds
US6274872B1 (en) * 1996-07-11 2001-08-14 Icb Institut Fuer Chemo- Und Biosensorik Menster E.V. Process and device for carrying out quantitative, fluorescence affinity tests
US6277651B1 (en) 1998-07-09 2001-08-21 Calspan Srl Corporation Diode laser electrochemical sensor for detecting chemical and biological analytes
US6297059B1 (en) 1998-06-22 2001-10-02 The Regents Of The University Of California Triggered optical biosensor
US6348322B1 (en) * 1997-10-17 2002-02-19 Duke University Method of screening for specific binding interactions
WO2002054076A2 (en) * 2000-12-29 2002-07-11 F. Hoffmann-La Roche Ag Sensor for luminescence optical determination of an analyte
US6475722B1 (en) * 1997-12-03 2002-11-05 Curagen Corporation Surface treatments for DNA processing devices
US20030003022A1 (en) * 2001-06-29 2003-01-02 Yoshiyuki Tamura Automatic smear preparing apparatus and automatic sample analysis system having the same
US20030036200A1 (en) * 2001-08-20 2003-02-20 Charlton Steven C. Packaging system for test sensors
US20030134959A1 (en) * 2001-11-30 2003-07-17 Hancock Lawrence F. Luminescent polymer particles
EP1347296A2 (en) 2002-03-18 2003-09-24 Bayer Healthcare, LLC Storage cartridge for biosensors
US20030178607A1 (en) * 1998-05-05 2003-09-25 Massachusetts Institute Of Technology Emissive polymers and devices incorporating these polymers
US20040037744A1 (en) * 1996-04-25 2004-02-26 Michael Seul Arrays formed of encoded beads having ligands attached
US6706479B2 (en) 2000-10-05 2004-03-16 Virginia Tech Intellectual Properties, Inc. Bio-chip, photoluminescent methods for identifying biological material, and apparatuses for use with such methods and bio-chips
US6743640B2 (en) * 2000-05-08 2004-06-01 Qtl Biosystems Llc Fluorescent polymer-QTL approach to biosensing
US20040116650A1 (en) * 2002-07-15 2004-06-17 Swager Timothy M. Emissive, high charge transport polymers
US20040121337A1 (en) * 2002-12-19 2004-06-24 Nomadics, Inc. Luminescent polymers and methods of use thereof
US6783814B2 (en) 2000-08-21 2004-08-31 Massachusetts Institute Of Technology Polymers with high internal free volume
WO2004081570A1 (en) * 2003-03-13 2004-09-23 Chengdu Kuachang Medical Industrial Limited A chip matrix, a chip comprising the matrix and their preparation and application
US20040206658A1 (en) * 2000-01-31 2004-10-21 The Penn State Research Foundation Interrogation of changes in the contents of a sealed container
US20040243093A1 (en) * 2001-01-10 2004-12-02 Ron Berenson System for growth, analysis, storage, validation and distribution of cells and tissues used for biomedical purposes
US20040258564A1 (en) * 2003-06-18 2004-12-23 Charlton Steven C. Containers for reading and handling diagnostic reagents and methods of using the same
US20040267299A1 (en) * 2003-06-30 2004-12-30 Kuriger Rex J. Lancing devices and methods of using the same
US20050141058A1 (en) * 2003-12-19 2005-06-30 Stmicroelectronics Ltd. Bio-optical sensors
US20050147534A1 (en) * 1998-05-05 2005-07-07 Massachusetts Institute Of Technology Emissive sensors and devices incorporating these sensors
WO2005064337A1 (en) * 2003-12-22 2005-07-14 Koninklijke Philips Electronics N.V. Optical nanowire biosensor based on energy transfer
WO2006045596A1 (en) * 2004-10-25 2006-05-04 F. Hoffmann-La Roche Ag Multifunctional reference system for use in analyte detection by fluorescence
US20060127929A1 (en) * 2004-09-17 2006-06-15 Massachusetts Institute Of Technology Polymers for analyte detection
US7083984B2 (en) 1993-09-24 2006-08-01 Biosite, Inc. Hybrid phthalocyanine derivatives and their uses
US20060172318A1 (en) * 2004-03-25 2006-08-03 Medinz Igor L Reagentless and reusable biosensors with tunable differential binding affinities and methods of making
US20060228740A1 (en) * 1996-04-25 2006-10-12 Michael Seul Light-controlled electrokinetic assembly of particles near surfaces
US7166475B2 (en) * 1999-02-26 2007-01-23 Cyclacel Ltd. Compositions and methods for monitoring the modification state of a pair of polypeptides
US20070062262A1 (en) * 2004-02-06 2007-03-22 Christina Blaschke Fluid testing sensor having vents for directing fluid flow
US20070081921A1 (en) * 1998-05-05 2007-04-12 Massachusetts Institute Of Technology Emissive polymers and devices incorporating these polymers
US20070148652A1 (en) * 2003-12-16 2007-06-28 Norrild Jens C Reagent for detecting an analyte
US7322927B2 (en) 1993-09-24 2008-01-29 Biosite, Inc. Hybrid phthalocyanine derivatives and their uses
US20080085566A1 (en) * 2006-10-05 2008-04-10 Massachusetts Institute Of Technology Emissive compositions with internal standard and related techniques
US20080087075A1 (en) * 2006-10-11 2008-04-17 Bayer Healthcare Llc Test sensor with a side vent and method of making the same
US20080105024A1 (en) * 2006-11-07 2008-05-08 Bayer Healthcare Llc Method of making an auto-calibrating test sensor
US20080188723A1 (en) * 2004-12-07 2008-08-07 Jesper Svennin Kristensen Sensor For Detection Of Carbohydrate
EP1978361A2 (en) 2007-04-06 2008-10-08 Bayer Healthcare, LLC Method for performing correction of blood glucose assay bias using blood hemoglobin concentration as determined by a glucose-hemoglobin A1C combination system and devices for same
US20090008246A1 (en) * 2004-10-20 2009-01-08 Reynolds Jeffrey S Cartridge for Containing and Dispensing Test Sensors
US20090042306A1 (en) * 2007-08-06 2009-02-12 Reynolds Jeffery S System and Method for Automatic Calibration
US20090131773A1 (en) * 2004-12-07 2009-05-21 Precisense A/S Sensor for Detection of Carbohydrate
EP2063252A1 (en) 2004-12-13 2009-05-27 Bayer Healthcare, LLC Transmission spectroscopy system for use in the determination of analytes in body fluid
US20090205399A1 (en) * 2008-02-15 2009-08-20 Bayer Healthcare, Llc Auto-calibrating test sensors
US20090215189A1 (en) * 2006-10-27 2009-08-27 Massachusetts Institute Of Technology Sensor of species including toxins and chemical warfare agents
US20090221891A1 (en) * 2004-05-19 2009-09-03 Yihua Yu Optical sensor for in vivo detection of analyte
US20090288964A1 (en) * 2006-12-13 2009-11-26 Sung-Kwon Jung Biosensor with coded information and method for manufacturing the same
US20100006773A1 (en) * 2004-07-27 2010-01-14 Precisense A/S Method and apparatus for measuring the phase shift induced in a light signal by a sample
US20100084466A1 (en) * 2008-10-07 2010-04-08 Bayer Healthcare Llc Method of forming an auto-calibration circuit or label
US20100090126A1 (en) * 2003-12-23 2010-04-15 Precisense A/S Fluorometers
US20100112715A1 (en) * 2006-08-04 2010-05-06 Swager Timothy M Detection of explosives, toxins, and other compositions
US20110198487A1 (en) * 2008-10-21 2011-08-18 Bayer Healthcare Llc Optical readhead and method of using the same
US8140148B2 (en) 1998-01-20 2012-03-20 Boston Scientific Scimed Ltd. Readable probe array for in vivo use
US8241488B2 (en) 2007-11-06 2012-08-14 Bayer Healthcare Llc Auto-calibrating test sensors
US8283423B2 (en) 2006-09-29 2012-10-09 Massachusetts Institute Of Technology Polymer synthetic technique
US8486629B2 (en) 2005-06-01 2013-07-16 Bioarray Solutions, Ltd. Creation of functionalized microparticle libraries by oligonucleotide ligation or elongation
US8486720B2 (en) 2000-06-21 2013-07-16 Bioarray Solutions, Ltd. Arrays of magnetic particles
US8563247B2 (en) 2003-10-29 2013-10-22 Bioarray Solutions, Ltd. Kits for multiplexed nucleic acid analysis by capture of single-stranded DNA produced from double-stranded target fragments
US8615367B2 (en) 2003-09-18 2013-12-24 Bioarray Solutions, Ltd. Number coding for identification of subtypes of coded types of solid phase carriers
US8691754B2 (en) 2003-09-22 2014-04-08 Bioarray Solutions, Ltd. Microparticles with enhanced covalent binding capacity and their uses
US8712123B2 (en) 2002-11-15 2014-04-29 Bioarray Solutions, Ltd. Analysis, secure access to, and transmission of array images
US8795960B2 (en) 2003-10-28 2014-08-05 Bioarray Solutions, Ltd. Optimization of gene expression analysis using immobilized capture probes
EP2851676A2 (en) 2008-12-18 2015-03-25 Bayer HealthCare LLC Method and assembly for determining the temperature of a test sensor
US9147037B2 (en) 2004-08-02 2015-09-29 Bioarray Solutions, Ltd. Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification
US9204829B2 (en) 2012-05-31 2015-12-08 Bayer Healthcare Llc Multistrip cartridge
WO2015195487A1 (en) 2014-06-19 2015-12-23 Bayer Healthcare Llc Sensor clip for stacked sensor dispensing system, and system using the same
US9383333B2 (en) 2012-05-31 2016-07-05 Ascensia Diabetes Care Holdings Ag Replaceable multistrip cartridge and biosensor meter
US9417229B2 (en) 2011-12-20 2016-08-16 Ascensia Diabetes Care Holdings Ag Linear, cartridge-based glucose measurement system
US9436088B2 (en) 2001-06-21 2016-09-06 Bioarray Solutions, Ltd. Un-supported polymeric film with embedded microbeads
US9617268B2 (en) 2011-12-30 2017-04-11 Ptc Therapeutics, Inc. Compounds for treating spinal muscular atrophy
US9709559B2 (en) 2000-06-21 2017-07-18 Bioarray Solutions, Ltd. Multianalyte molecular analysis using application-specific random particle arrays
US10359573B2 (en) 1999-11-05 2019-07-23 Board Of Regents, The University Of Texas System Resonant waveguide-granting devices and methods for using same
US10415081B2 (en) 2001-10-15 2019-09-17 Bioarray Solutions Ltd. Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection
US10533949B2 (en) 2013-03-12 2020-01-14 Ascensia Diabetes Care Holdings Ag Test strip meter with a mechanism for pushing the test strip against an optical reader
US20200166456A1 (en) * 2018-09-27 2020-05-28 Cornell University Super-resolution optical imaging of non-fluorescent species
US10842427B2 (en) 2005-09-30 2020-11-24 Intuity Medical, Inc. Body fluid sampling arrangements
US10871483B2 (en) 2013-03-13 2020-12-22 Ascensia Diabetes Care Holdings Ag Bottled glucose sensor with no handling
US11002743B2 (en) 2009-11-30 2021-05-11 Intuity Medical, Inc. Calibration material delivery devices and methods
US11045125B2 (en) 2008-05-30 2021-06-29 Intuity Medical, Inc. Body fluid sampling device-sampling site interface
US11051734B2 (en) 2011-08-03 2021-07-06 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
US11399744B2 (en) 2008-06-06 2022-08-02 Intuity Medical, Inc. Detection meter and mode of operation
US11419532B2 (en) 2005-06-13 2022-08-23 Intuity Medical, Inc. Analyte detection devices and methods with hematocrit/volume correction and feedback control

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4121426A1 (en) * 1991-06-28 1993-01-14 Basf Ag CHEMICAL SENSOR
US5587472A (en) * 1991-08-13 1996-12-24 Bayer Corporation Coumarin-labeled nucleoside 5'-triphosphates
US5246867A (en) * 1992-01-17 1993-09-21 University Of Maryland At Baltimore Determination and quantification of saccharides by luminescence lifetimes and energy transfer
CA2087412A1 (en) * 1992-01-17 1993-07-18 Joseph R. Lakowicz Ph and pco2 sensing by luminescent lifetimes and energy transfer
DE4319037A1 (en) * 1993-06-08 1994-12-15 Bayer Ag Coated carriers, processes for their preparation and their use for the immobilization of biomolecules on surfaces of solids
US6596522B2 (en) 1997-05-08 2003-07-22 The Regents Of The University Of California Detection of transmembrane potentials by optical methods
US5661035A (en) * 1995-06-07 1997-08-26 The Regents Of The University Of California Voltage sensing by fluorescence resonance energy transfer
US6342379B1 (en) 1995-06-07 2002-01-29 The Regents Of The University Of California Detection of transmembrane potentials by optical methods
DE19530078A1 (en) * 1995-08-16 1997-02-20 Bayer Ag Optical solid phase biosensor based on streptavidin and biotin
US8329390B2 (en) 2004-10-21 2012-12-11 Anaspec Incorporated Detection of transmembrane potentials using N,N,N′-trialkyl thiobarbituric acid-derived polymethine oxonols

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261968A (en) * 1979-05-10 1981-04-14 Syva Company Fluorescence quenching with immunological pairs in immunoassays
EP0150905A2 (en) * 1984-01-05 1985-08-07 Ortho Diagnostic Systems Inc. Anti-idiotype assay using fluorescent energy transfer
EP0174744A2 (en) * 1984-08-14 1986-03-19 Ortho Diagnostic Systems Inc. Fluorescent energy transfer with phycobiliproteins
US4777128A (en) * 1986-05-27 1988-10-11 Ethigen Corporation Fluorescence immunoassay involving energy transfer between two fluorophores
US4820649A (en) * 1986-09-22 1989-04-11 Teijin Limited Method and kit having layered device for detecting biological component by interference color
US5037615A (en) * 1987-10-30 1991-08-06 Cordis Corporation Tethered pair fluorescence energy transfer indicators, chemical sensors, and method of making such sensors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62294085A (en) * 1986-06-13 1987-12-21 Seiko Instr & Electronics Ltd Organic thin film, production thereof and element utilizing said organic thin film

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261968A (en) * 1979-05-10 1981-04-14 Syva Company Fluorescence quenching with immunological pairs in immunoassays
EP0150905A2 (en) * 1984-01-05 1985-08-07 Ortho Diagnostic Systems Inc. Anti-idiotype assay using fluorescent energy transfer
EP0174744A2 (en) * 1984-08-14 1986-03-19 Ortho Diagnostic Systems Inc. Fluorescent energy transfer with phycobiliproteins
US4777128A (en) * 1986-05-27 1988-10-11 Ethigen Corporation Fluorescence immunoassay involving energy transfer between two fluorophores
US4820649A (en) * 1986-09-22 1989-04-11 Teijin Limited Method and kit having layered device for detecting biological component by interference color
US5037615A (en) * 1987-10-30 1991-08-06 Cordis Corporation Tethered pair fluorescence energy transfer indicators, chemical sensors, and method of making such sensors

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
Annual Reviews of Biochemistry, Bol. 47, 1978, pp. 819 846, Palo Alto, Calif. *
Annual Reviews of Biochemistry, Bol. 47, 1978, pp. 819-846, Palo Alto, Calif.
Chemical Abstracts, vol. 110, No. 6, Feb. 6, 1989, p. 787, Zusammenfassung No. 50443g. *
Chemical Abstracts, vol. 112, No. 4, Jan. 22, 1990, p. 631 Zusammenfassung No. 29895n. *
Nature, vol. 320, No. 13, Mar. 1986, pp. 179 181, London. *
Nature, vol. 320, No. 13, Mar. 1986, pp. 179-181, London.
WPIL. File Supplier, AN 88 033622, Derwent Publications Ltd. London. *
WPIL. File Supplier, AN=88-033622, Derwent Publications Ltd. London.

Cited By (210)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5711915A (en) * 1992-03-18 1998-01-27 Bayer Aktiengesellschaft Optical solid-phase biosensor based on polyionic layers labelled with fluorescent dyes
US5512328A (en) * 1992-08-07 1996-04-30 Hitachi, Ltd. Method for forming a pattern and forming a thin film used in pattern formation
US5552272A (en) * 1993-06-10 1996-09-03 Biostar, Inc. Detection of an analyte by fluorescence using a thin film optical device
US5763189A (en) * 1993-09-24 1998-06-09 Biosite Diagnostics Incorporated Fluorescence energy transfer and intramolecular energy transfer in particles using novel compounds
US7322927B2 (en) 1993-09-24 2008-01-29 Biosite, Inc. Hybrid phthalocyanine derivatives and their uses
US5824799A (en) * 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
US6251687B1 (en) 1993-09-24 2001-06-26 Biosite Diagnostics, Inc. Fluorescence energy transfer and intramolecular energy transfer in particles using novel compounds
US7083984B2 (en) 1993-09-24 2006-08-01 Biosite, Inc. Hybrid phthalocyanine derivatives and their uses
US5496522A (en) * 1994-02-07 1996-03-05 Martin Marietta Energy Systems, Inc. Biosensor and chemical sensor probes for calcium and other metal ions
US5577137A (en) * 1995-02-22 1996-11-19 American Research Corporation Of Virginia Optical chemical sensor and method using same employing a multiplicity of fluorophores contained in the free volume of a polymeric optical waveguide or in pores of a ceramic waveguide
US5871915A (en) * 1995-03-13 1999-02-16 Research Development Corporation Of Japan Method for detecting nucleic acid polymer
US6020131A (en) * 1995-03-13 2000-02-01 Research Development Corporation Of Japan Nucleic acid polymer/intercalator monolayer and methods of using and making thereof
US5591407A (en) * 1995-04-21 1997-01-07 American Research Corporation Of Virginia Laser diode sensor
US5690894A (en) * 1995-05-23 1997-11-25 The Regents Of The University Of California High density array fabrication and readout method for a fiber optic biosensor
US6146593A (en) * 1995-05-23 2000-11-14 The Regents Of The University Of California High density array fabrication and readout method for a fiber optic biosensor
US6417506B1 (en) 1995-05-23 2002-07-09 The Regents Of The University Of California High density array fabrication and readout method for a fiber optic biosensor
US5792621A (en) * 1995-06-28 1998-08-11 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Fiber-optic chemiluminescent biosensors for monitoring aqueous alcohols and other water quality parameters
EP0879299A1 (en) * 1996-01-26 1998-11-25 The Regents Of The University Of California High density array fabrication and readout method for a fiber optic biosensor
US5837196A (en) * 1996-01-26 1998-11-17 The Regents Of The University Of California High density array fabrication and readout method for a fiber optic biosensor
EP0879299A4 (en) * 1996-01-26 2001-04-18 Univ California High density array fabrication and readout method for a fiber optic biosensor
US5854863A (en) * 1996-03-15 1998-12-29 Erb; Judith Surface treatment and light injection method and apparatus
US5952035A (en) * 1996-03-15 1999-09-14 Ia, Inc. Surface treatment and light injection method and apparatus
US5841914A (en) * 1996-04-17 1998-11-24 Motorola, Inc. Molecular detection apparatus and method using optical waveguide detection
US5671303A (en) * 1996-04-17 1997-09-23 Motorola, Inc. Molecular detection apparatus and method using optical waveguide detection
US9400259B2 (en) 1996-04-25 2016-07-26 Bioarray Solutions, Ltd. Method of making a microbead array with attached biomolecules
US20070154934A1 (en) * 1996-04-25 2007-07-05 Michael Seul Assays Employing Randomly Distributed Microbeads with Attached Biomolecules
US8039271B2 (en) 1996-04-25 2011-10-18 Bioarray Solutions, Ltd. Assays employing randomly distributed microbeads with attached biomolecules
US20060228741A1 (en) * 1996-04-25 2006-10-12 Seul Michael Light-controlled electrokinetic assembly of particles near surfaces
US20060228740A1 (en) * 1996-04-25 2006-10-12 Michael Seul Light-controlled electrokinetic assembly of particles near surfaces
US8071393B2 (en) 1996-04-25 2011-12-06 Bioarray Solutions, Ltd. Method of analyzing nucleic acids using an array of encoded beads
US8124402B2 (en) 1996-04-25 2012-02-28 Bioarray Solutions, Ltd. Encoded beads having oligonucleotides attached in arrays on a patterned surface
US7749774B2 (en) * 1996-04-25 2010-07-06 Michael Seul Arrays formed of encoded beads having ligands attached
US20040037744A1 (en) * 1996-04-25 2004-02-26 Michael Seul Arrays formed of encoded beads having ligands attached
US20070259449A1 (en) * 1996-04-25 2007-11-08 Michael Seul Method of making a microbead array with attached biomolecules
US8309368B2 (en) 1996-04-25 2012-11-13 Bioarray Solutions, Ltd. Method of making a microbead array with attached biomolecules
US8691594B2 (en) 1996-04-25 2014-04-08 Bioarray Solutions, Ltd. Method of making a microbead array with attached biomolecules
US20080038844A1 (en) * 1996-04-25 2008-02-14 Michael Seul Method of Analyzing Nucleic Acids Using an Array of Encoded Beads
US6103535A (en) * 1996-05-31 2000-08-15 University Of Maryland Optical fiber evanescent field excited fluorosensor and method of manufacture
US6235535B1 (en) * 1996-06-28 2001-05-22 Valtion Teknillinen Tutkimuskeskus Fluorescent energy transfer ligand interaction assay on a lipid film
US6274872B1 (en) * 1996-07-11 2001-08-14 Icb Institut Fuer Chemo- Und Biosensorik Menster E.V. Process and device for carrying out quantitative, fluorescence affinity tests
US20020142335A1 (en) * 1997-10-17 2002-10-03 Strittmatter Warren J. Method of screening for specific binding interactions
US6348322B1 (en) * 1997-10-17 2002-02-19 Duke University Method of screening for specific binding interactions
US6475722B1 (en) * 1997-12-03 2002-11-05 Curagen Corporation Surface treatments for DNA processing devices
US8140148B2 (en) 1998-01-20 2012-03-20 Boston Scientific Scimed Ltd. Readable probe array for in vivo use
US6051437A (en) * 1998-05-04 2000-04-18 American Research Corporation Of Virginia Optical chemical sensor based on multilayer self-assembled thin film sensors for aquaculture process control
US7393503B2 (en) 1998-05-05 2008-07-01 Massachusetts Institute Of Technology Emissive polymers and devices incorporating these polymers
US20060120923A1 (en) * 1998-05-05 2006-06-08 Swager Timothy M Emissive polymers and devices incorporating these polymers
US20030178607A1 (en) * 1998-05-05 2003-09-25 Massachusetts Institute Of Technology Emissive polymers and devices incorporating these polymers
US7662309B2 (en) 1998-05-05 2010-02-16 Massachusetts Institute Of Technology Emissive polymers and devices incorporating these polymers
US7208122B2 (en) 1998-05-05 2007-04-24 Massachusetts Institute Of Technology Emissive polymers and devices incorporating these polymers
US20070081921A1 (en) * 1998-05-05 2007-04-12 Massachusetts Institute Of Technology Emissive polymers and devices incorporating these polymers
US20100213451A1 (en) * 1998-05-05 2010-08-26 Massachusetts Institute Of Technology Emissive polymers and devices incorporating these polymers
US7943062B2 (en) 1998-05-05 2011-05-17 Massachusetts Institute Of Technology Emissive polymers and devices incorporating these polymers
US20110142717A1 (en) * 1998-05-05 2011-06-16 Massachusetts Institute Of Technology Emissive sensors and devices incorporating these sensors
US8465678B2 (en) 1998-05-05 2013-06-18 Massachusetts Institute Of Technology Emissive polymers and devices incorporating these polymers
US20050147534A1 (en) * 1998-05-05 2005-07-07 Massachusetts Institute Of Technology Emissive sensors and devices incorporating these sensors
US8367001B2 (en) 1998-05-05 2013-02-05 Massachusetts Institute Of Technology Emissive sensors and devices incorporating these sensors
US8198096B2 (en) 1998-05-05 2012-06-12 Massachusetts Institute Of Technology Emissive polymers and devices incorporating these polymers
US20060120917A1 (en) * 1998-05-05 2006-06-08 Swager Timothy M Emissive polymers and devices incorporating these polymers
US6297059B1 (en) 1998-06-22 2001-10-02 The Regents Of The University Of California Triggered optical biosensor
US6277651B1 (en) 1998-07-09 2001-08-21 Calspan Srl Corporation Diode laser electrochemical sensor for detecting chemical and biological analytes
US7166475B2 (en) * 1999-02-26 2007-01-23 Cyclacel Ltd. Compositions and methods for monitoring the modification state of a pair of polypeptides
US10359573B2 (en) 1999-11-05 2019-07-23 Board Of Regents, The University Of Texas System Resonant waveguide-granting devices and methods for using same
US20090023203A1 (en) * 2000-01-31 2009-01-22 The Penn State Research Foundation Sensor Device for Interrogation of Changes in the Contents of a Sealed Container
US20040206658A1 (en) * 2000-01-31 2004-10-21 The Penn State Research Foundation Interrogation of changes in the contents of a sealed container
US7407796B2 (en) * 2000-01-31 2008-08-05 The Penn State Research Foundation Interrogation of changes in the contents of a sealed container
US6743640B2 (en) * 2000-05-08 2004-06-01 Qtl Biosystems Llc Fluorescent polymer-QTL approach to biosensing
US9709559B2 (en) 2000-06-21 2017-07-18 Bioarray Solutions, Ltd. Multianalyte molecular analysis using application-specific random particle arrays
US8486720B2 (en) 2000-06-21 2013-07-16 Bioarray Solutions, Ltd. Arrays of magnetic particles
US6783814B2 (en) 2000-08-21 2004-08-31 Massachusetts Institute Of Technology Polymers with high internal free volume
US7494698B2 (en) 2000-08-21 2009-02-24 Massachusetts Institute Of Technology Polymers with high internal free volume
US20080188634A1 (en) * 2000-08-21 2008-08-07 Massachusetts Institute Of Technology Polymers with high internal free volume
US20040170775A1 (en) * 2000-08-21 2004-09-02 Swager Timothy M. Polymers with high internal free volume
US6706479B2 (en) 2000-10-05 2004-03-16 Virginia Tech Intellectual Properties, Inc. Bio-chip, photoluminescent methods for identifying biological material, and apparatuses for use with such methods and bio-chips
US7456023B2 (en) 2000-12-29 2008-11-25 Roche Diagnostics Operations, Inc. Reagent for luminescence optical determination of an analyte
US20040175836A1 (en) * 2000-12-29 2004-09-09 Ingo Klimant Reagent for luminescence optical determination of an analyte
WO2002054076A2 (en) * 2000-12-29 2002-07-11 F. Hoffmann-La Roche Ag Sensor for luminescence optical determination of an analyte
WO2002054045A3 (en) * 2000-12-29 2003-03-20 Hoffmann La Roche Reagent for luminescence optical determination of an analyte
WO2002054045A2 (en) * 2000-12-29 2002-07-11 F.Hoffmann-La Roche Ag Reagent for luminescence optical determination of an analyte
WO2002054076A3 (en) * 2000-12-29 2002-10-10 Hoffmann La Roche Sensor for luminescence optical determination of an analyte
US7067320B2 (en) 2000-12-29 2006-06-27 Roche Diagnostics Operations, Inc. Sensor for luminescense-optical determination of an analyte
US20040166024A1 (en) * 2000-12-29 2004-08-26 Ingo Klimant Sensor for luminescense-optical determination of an analyte
US20040243093A1 (en) * 2001-01-10 2004-12-02 Ron Berenson System for growth, analysis, storage, validation and distribution of cells and tissues used for biomedical purposes
US20070255249A1 (en) * 2001-01-10 2007-11-01 Ron Berenson System for growth, analysis, storage, validation and distribution of cells and tissues used for biomedical purposes
US9436088B2 (en) 2001-06-21 2016-09-06 Bioarray Solutions, Ltd. Un-supported polymeric film with embedded microbeads
US7297311B2 (en) * 2001-06-29 2007-11-20 Sysmex Corporation Automatic smear preparing apparatus and automatic sample analysis system having the same
US20030003022A1 (en) * 2001-06-29 2003-01-02 Yoshiyuki Tamura Automatic smear preparing apparatus and automatic sample analysis system having the same
US20030036200A1 (en) * 2001-08-20 2003-02-20 Charlton Steven C. Packaging system for test sensors
US7723113B2 (en) 2001-08-20 2010-05-25 Bayer Healthcare Llc Packaging system for test sensors
US10415081B2 (en) 2001-10-15 2019-09-17 Bioarray Solutions Ltd. Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection
US7462325B2 (en) 2001-11-30 2008-12-09 Nomadics, Inc. Luminescent polymer particles
US20030134959A1 (en) * 2001-11-30 2003-07-17 Hancock Lawrence F. Luminescent polymer particles
EP1347296A2 (en) 2002-03-18 2003-09-24 Bayer Healthcare, LLC Storage cartridge for biosensors
US7041910B2 (en) 2002-07-15 2006-05-09 Massachusetts Institute Of Technology Emissive, high charge transport polymers
US20040116650A1 (en) * 2002-07-15 2004-06-17 Swager Timothy M. Emissive, high charge transport polymers
US8712123B2 (en) 2002-11-15 2014-04-29 Bioarray Solutions, Ltd. Analysis, secure access to, and transmission of array images
US9251583B2 (en) 2002-11-15 2016-02-02 Bioarray Solutions, Ltd. Analysis, secure access to, and transmission of array images
US20040121337A1 (en) * 2002-12-19 2004-06-24 Nomadics, Inc. Luminescent polymers and methods of use thereof
WO2004081570A1 (en) * 2003-03-13 2004-09-23 Chengdu Kuachang Medical Industrial Limited A chip matrix, a chip comprising the matrix and their preparation and application
US7364699B2 (en) 2003-06-18 2008-04-29 Bayer Healthcare Llc Containers for reading and handling diagnostic reagents and methods of using the same
US20110165685A1 (en) * 2003-06-18 2011-07-07 Bayer Healthcare Llc Containers for reading and handling diagnostic reagents and methods of using the same
US20040258564A1 (en) * 2003-06-18 2004-12-23 Charlton Steven C. Containers for reading and handling diagnostic reagents and methods of using the same
US7927545B2 (en) 2003-06-18 2011-04-19 Bayer Healthcare Llc Containers for reading and handling diagnostic reagents and methods for using the same
US20100233025A1 (en) * 2003-06-18 2010-09-16 Bayer Healthcare Llc Containers For Reading And Handling Diagnostic Reagents And Methods For Using The Same
US8178351B2 (en) 2003-06-18 2012-05-15 Bayer Healthcare Llc Containers for reading and handling diagnostic reagents and methods of using the same
US7749454B2 (en) 2003-06-18 2010-07-06 Bayer Healthcare, Llc Containers for reading and handling diagnostic reagents and methods of using the same
US20080199364A1 (en) * 2003-06-18 2008-08-21 Bayer Healthcare Llc Containers for reading and handling diagnostic reagents and methods of using the same
US20040267299A1 (en) * 2003-06-30 2004-12-30 Kuriger Rex J. Lancing devices and methods of using the same
US8615367B2 (en) 2003-09-18 2013-12-24 Bioarray Solutions, Ltd. Number coding for identification of subtypes of coded types of solid phase carriers
US8691754B2 (en) 2003-09-22 2014-04-08 Bioarray Solutions, Ltd. Microparticles with enhanced covalent binding capacity and their uses
US9637777B2 (en) 2003-10-28 2017-05-02 Bioarray Solutions, Ltd. Optimization of gene expression analysis using immobilized capture probes
US8795960B2 (en) 2003-10-28 2014-08-05 Bioarray Solutions, Ltd. Optimization of gene expression analysis using immobilized capture probes
US8563247B2 (en) 2003-10-29 2013-10-22 Bioarray Solutions, Ltd. Kits for multiplexed nucleic acid analysis by capture of single-stranded DNA produced from double-stranded target fragments
US7892748B2 (en) 2003-12-16 2011-02-22 Precisense A/S Reagent for detecting an analyte
US8318443B2 (en) 2003-12-16 2012-11-27 Medtronic Minimed, Inc. Reagent for detecting an analyte
US20070148652A1 (en) * 2003-12-16 2007-06-28 Norrild Jens C Reagent for detecting an analyte
US20110111519A1 (en) * 2003-12-16 2011-05-12 Precisense A/S Reagent for detecting an analyte
US20050141058A1 (en) * 2003-12-19 2005-06-30 Stmicroelectronics Ltd. Bio-optical sensors
US7447385B2 (en) * 2003-12-19 2008-11-04 Stmicroelectronics Ltd. Bio-optical sensors
WO2005064337A1 (en) * 2003-12-22 2005-07-14 Koninklijke Philips Electronics N.V. Optical nanowire biosensor based on energy transfer
JP2007515639A (en) * 2003-12-22 2007-06-14 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Optical nanowire biosensor based on energy transfer
US7869042B2 (en) 2003-12-23 2011-01-11 Precisense A/S Fluorometers
US8305580B2 (en) 2003-12-23 2012-11-06 Precisense A/S Fluorometers
US20110089341A1 (en) * 2003-12-23 2011-04-21 Precisense A/S Fluorometers
US20100090126A1 (en) * 2003-12-23 2010-04-15 Precisense A/S Fluorometers
US20070062262A1 (en) * 2004-02-06 2007-03-22 Christina Blaschke Fluid testing sensor having vents for directing fluid flow
US7543481B2 (en) 2004-02-06 2009-06-09 Bayer Healthcare, Llc Fluid testing sensor having vents for directing fluid flow
WO2006096185A3 (en) * 2004-03-25 2009-04-02 Us Gov Sec Navy Reagentless and reusable biosensors with tunable differential binding affinites and methods of making
US7927547B2 (en) * 2004-03-25 2011-04-19 The Government Of The United States Of America, As Represented By The Secretary Of The Navy Reagentless and reusable biosensors with tunable differential binding affinities and methods of making
WO2006096185A2 (en) * 2004-03-25 2006-09-14 The Government Of The United States Of American, As Represented By The Secretary Of The Navy Reagentless and reusable biosensors with tunable differential binding affinites and methods of making
US7435386B2 (en) * 2004-03-25 2008-10-14 The United States Of America As Represented By The Secretary Of The Navy Reagentless and reusable biosensors with tunable differential binding affinities and methods of making
US20060172318A1 (en) * 2004-03-25 2006-08-03 Medinz Igor L Reagentless and reusable biosensors with tunable differential binding affinities and methods of making
US20090048123A1 (en) * 2004-03-25 2009-02-19 The Government Of The Us, As Represented By The Secretary Of The Navy Reagentless and Reusable Biosensors with Tunable Differential Binding Affinities and Methods of Making
US9399076B2 (en) 2004-05-19 2016-07-26 Medtronic Minimed, Inc. Optical sensor for in vivo detection of analyte
US20090221891A1 (en) * 2004-05-19 2009-09-03 Yihua Yu Optical sensor for in vivo detection of analyte
US8080810B2 (en) 2004-07-27 2011-12-20 Medtronic Minimed, Inc. Method and apparatus for measuring the phase shift iduced in a light signal by a sample
US7884338B2 (en) 2004-07-27 2011-02-08 Precisense A/S Method and apparatus for measuring the phase shift induced in a light signal by a sample
US20100006773A1 (en) * 2004-07-27 2010-01-14 Precisense A/S Method and apparatus for measuring the phase shift induced in a light signal by a sample
US20110095204A1 (en) * 2004-07-27 2011-04-28 Precisense A/S Method and apparatus for measuring the phase shift iduced in a light signal by a sample
US9147037B2 (en) 2004-08-02 2015-09-29 Bioarray Solutions, Ltd. Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification
US20060127929A1 (en) * 2004-09-17 2006-06-15 Massachusetts Institute Of Technology Polymers for analyte detection
US8617819B2 (en) 2004-09-17 2013-12-31 Massachusetts Institute Of Technology Polymers for analyte detection
US20090008246A1 (en) * 2004-10-20 2009-01-08 Reynolds Jeffrey S Cartridge for Containing and Dispensing Test Sensors
US8759112B2 (en) 2004-10-25 2014-06-24 Roche Diagnostics Operations, Inc. Multifunctional reference system for analyte determinations by fluorescence
US20080014655A1 (en) * 2004-10-25 2008-01-17 Roche Diagnostics Operations, Inc. Multifunctional Reference System For Analyte Determinations By Fluorescence
WO2006045596A1 (en) * 2004-10-25 2006-05-04 F. Hoffmann-La Roche Ag Multifunctional reference system for use in analyte detection by fluorescence
US8691517B2 (en) 2004-12-07 2014-04-08 Medtronic Minimed, Inc. Flexible carbohydrate-bearing polymer
US8478375B2 (en) 2004-12-07 2013-07-02 Medtronic Minimed, Inc. Sensor for detection of carbohydrate
US20090131773A1 (en) * 2004-12-07 2009-05-21 Precisense A/S Sensor for Detection of Carbohydrate
US20090187084A1 (en) * 2004-12-07 2009-07-23 Precisence A/S Flexible Carbohydrate-Bearing Polymer
US8700113B2 (en) 2004-12-07 2014-04-15 Medtronic Minimed, Inc. Sensor for detection of carbohydrate
US20080188723A1 (en) * 2004-12-07 2008-08-07 Jesper Svennin Kristensen Sensor For Detection Of Carbohydrate
EP2063252A1 (en) 2004-12-13 2009-05-27 Bayer Healthcare, LLC Transmission spectroscopy system for use in the determination of analytes in body fluid
US8184273B2 (en) 2004-12-13 2012-05-22 Bayer Healthcare Llc Method of determining glucose concentration of a whole blood sample
EP3062086A1 (en) 2004-12-13 2016-08-31 Ascensia Diabetes Care Holdings AG Transmission spectroscopy system for use in the determination of analytes in body fluid
US20110102768A1 (en) * 2004-12-13 2011-05-05 Bayer Healthcare Llc Method of determining glucose concentration of a whole blood sample
US8486629B2 (en) 2005-06-01 2013-07-16 Bioarray Solutions, Ltd. Creation of functionalized microparticle libraries by oligonucleotide ligation or elongation
US11419532B2 (en) 2005-06-13 2022-08-23 Intuity Medical, Inc. Analyte detection devices and methods with hematocrit/volume correction and feedback control
US10842427B2 (en) 2005-09-30 2020-11-24 Intuity Medical, Inc. Body fluid sampling arrangements
US8158437B2 (en) 2006-08-04 2012-04-17 Massachusetts Institute Of Technology Luminescent detection of hydrazine and hydrazine derivatives
US20100112715A1 (en) * 2006-08-04 2010-05-06 Swager Timothy M Detection of explosives, toxins, and other compositions
US8283423B2 (en) 2006-09-29 2012-10-09 Massachusetts Institute Of Technology Polymer synthetic technique
US20080085566A1 (en) * 2006-10-05 2008-04-10 Massachusetts Institute Of Technology Emissive compositions with internal standard and related techniques
US8802447B2 (en) 2006-10-05 2014-08-12 Massachusetts Institute Of Technology Emissive compositions with internal standard and related techniques
US7797987B2 (en) 2006-10-11 2010-09-21 Bayer Healthcare Llc Test sensor with a side vent and method of making the same
US20080087075A1 (en) * 2006-10-11 2008-04-17 Bayer Healthcare Llc Test sensor with a side vent and method of making the same
US20090215189A1 (en) * 2006-10-27 2009-08-27 Massachusetts Institute Of Technology Sensor of species including toxins and chemical warfare agents
US9429522B2 (en) 2006-10-27 2016-08-30 Massachusetts Institute Of Technology Sensor of species including toxins and chemical warfare agents
US20080105024A1 (en) * 2006-11-07 2008-05-08 Bayer Healthcare Llc Method of making an auto-calibrating test sensor
US20090288964A1 (en) * 2006-12-13 2009-11-26 Sung-Kwon Jung Biosensor with coded information and method for manufacturing the same
EP1978361A2 (en) 2007-04-06 2008-10-08 Bayer Healthcare, LLC Method for performing correction of blood glucose assay bias using blood hemoglobin concentration as determined by a glucose-hemoglobin A1C combination system and devices for same
US20080248581A1 (en) * 2007-04-06 2008-10-09 Bayer Healthcare Llc Method for performing correction of blood glucose assay bias using blood hemoglobin concentration
US7981678B2 (en) 2007-08-06 2011-07-19 Bayer Healthcare Llc System and method for automatic calibration
US20090042306A1 (en) * 2007-08-06 2009-02-12 Reynolds Jeffery S System and Method for Automatic Calibration
US8241488B2 (en) 2007-11-06 2012-08-14 Bayer Healthcare Llc Auto-calibrating test sensors
US20090205399A1 (en) * 2008-02-15 2009-08-20 Bayer Healthcare, Llc Auto-calibrating test sensors
US11045125B2 (en) 2008-05-30 2021-06-29 Intuity Medical, Inc. Body fluid sampling device-sampling site interface
US11399744B2 (en) 2008-06-06 2022-08-02 Intuity Medical, Inc. Detection meter and mode of operation
US20100084466A1 (en) * 2008-10-07 2010-04-08 Bayer Healthcare Llc Method of forming an auto-calibration circuit or label
US8424763B2 (en) 2008-10-07 2013-04-23 Bayer Healthcare Llc Method of forming an auto-calibration circuit or label
US8586911B2 (en) 2008-10-21 2013-11-19 Bayer Healthcare Llc Optical readhead and method of using the same
US8981284B2 (en) 2008-10-21 2015-03-17 Bayer Healthcare Llc Method of determining information of a test sensor
US20110198487A1 (en) * 2008-10-21 2011-08-18 Bayer Healthcare Llc Optical readhead and method of using the same
US8742327B2 (en) 2008-10-21 2014-06-03 Bayer Healthcare Llc Method of determining auto-calibration of a test sensor
EP2851676A2 (en) 2008-12-18 2015-03-25 Bayer HealthCare LLC Method and assembly for determining the temperature of a test sensor
EP3214432A1 (en) 2008-12-18 2017-09-06 Ascensia Diabetes Care Holdings AG Method and assembly for determining the temperature of a test sensor
US11002743B2 (en) 2009-11-30 2021-05-11 Intuity Medical, Inc. Calibration material delivery devices and methods
US11933789B2 (en) 2009-11-30 2024-03-19 Intuity Medical, Inc. Calibration material delivery devices and methods
US11672452B2 (en) 2011-08-03 2023-06-13 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
US11382544B2 (en) 2011-08-03 2022-07-12 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
US11051734B2 (en) 2011-08-03 2021-07-06 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
US9417229B2 (en) 2011-12-20 2016-08-16 Ascensia Diabetes Care Holdings Ag Linear, cartridge-based glucose measurement system
US11226327B2 (en) 2011-12-20 2022-01-18 Ascensia Diabetes Care Holdings Ag Linear, cartridge-based glucose measurement system
US9617268B2 (en) 2011-12-30 2017-04-11 Ptc Therapeutics, Inc. Compounds for treating spinal muscular atrophy
USRE47689E1 (en) 2011-12-30 2019-11-05 Ptc Therapeutics, Inc. Compounds for treating spinal muscular atrophy
US10753923B2 (en) 2012-05-31 2020-08-25 Ascensia Diabetes Care Holdings Ag Multistrip cartridge
EP3588086A2 (en) 2012-05-31 2020-01-01 Ascensia Diabetes Care Holdings AG Replaceable multistrip cartridge and biosensor meter
US10324081B2 (en) 2012-05-31 2019-06-18 Ascensia Diabetes Care Holdings Ag Multistrip cartridge
US10073051B2 (en) 2012-05-31 2018-09-11 Ascensia Diabetes Care Holdings Ag Replaceable multistrip cartridge and biosensor meter
US9383333B2 (en) 2012-05-31 2016-07-05 Ascensia Diabetes Care Holdings Ag Replaceable multistrip cartridge and biosensor meter
US9204829B2 (en) 2012-05-31 2015-12-08 Bayer Healthcare Llc Multistrip cartridge
EP3296738A1 (en) 2012-05-31 2018-03-21 Ascensia Diabetes Care Holdings AG Replaceable multistrip cartridge and biosensor meter
US10656112B2 (en) 2012-05-31 2020-05-19 Ascensia Diabetes Care Holdings Ag Replaceable multistrip cartridge and biosenser meter
US10533949B2 (en) 2013-03-12 2020-01-14 Ascensia Diabetes Care Holdings Ag Test strip meter with a mechanism for pushing the test strip against an optical reader
US10871483B2 (en) 2013-03-13 2020-12-22 Ascensia Diabetes Care Holdings Ag Bottled glucose sensor with no handling
WO2015195487A1 (en) 2014-06-19 2015-12-23 Bayer Healthcare Llc Sensor clip for stacked sensor dispensing system, and system using the same
US10712335B2 (en) 2014-06-19 2020-07-14 Ascensia Diabetes Care Holdings Ag Sensor clip for stacked sensor dispensing system, and systems, methods and devices for making and using the same
US11808756B2 (en) 2014-06-19 2023-11-07 Ascensia Diabetes Care Holdings Ag Sensor clip for stacked sensor dispensing system, and systems, methods and devices for making and using the same
EP3663759A1 (en) 2014-06-19 2020-06-10 Ascensia Diabetes Care Holdings AG Sensor clip assembly for stacked sensor dispensing system
US20200166456A1 (en) * 2018-09-27 2020-05-28 Cornell University Super-resolution optical imaging of non-fluorescent species

Also Published As

Publication number Publication date
EP0429907A3 (en) 1991-10-16
EP0429907B1 (en) 1994-06-01
FI905701A0 (en) 1990-11-19
ATE106566T1 (en) 1994-06-15
DK0429907T3 (en) 1994-10-03
CA2030244A1 (en) 1991-05-22
FI98570B (en) 1997-03-27
DE59005928D1 (en) 1994-07-07
JPH03176662A (en) 1991-07-31
FI98570C (en) 1997-07-10
FI905701A (en) 1991-05-22
EP0429907A2 (en) 1991-06-05

Similar Documents

Publication Publication Date Title
US5194393A (en) Optical biosensor and method of use
US5711915A (en) Optical solid-phase biosensor based on polyionic layers labelled with fluorescent dyes
US6297059B1 (en) Triggered optical biosensor
Stefan et al. Immunosensors in clinical analysis
CA2723436C (en) Analyte detecting sensor with coated transducer
JP2003528309A (en) Sample detection method using fluorescence
EP2839284B1 (en) A microparticle assembly
CN101339135A (en) Method for promoting biological detection sensitivity by photon crystal
CA2183204A1 (en) Optical solid-phase biosensor based on streptavidin and biotin
US5401469A (en) Plastic optical biomaterials assay device
Marks et al. An innovative strategy for immobilization of receptor proteins on to an optical fiber by use of poly (pyrrole–biotin)
EP2224241B1 (en) Carrier for use in measurement of analyte, and method for production thereof
JP4397304B2 (en) Biosensor
US6939721B2 (en) Fluorescence immunoassays using organo-metallic complexes for energy transfer
WO1998002743A1 (en) Sensors
EP0988549B1 (en) Modular assembly for reagentless affinity separation and detection of analyte
US9285322B2 (en) pH modulation methods and systems for detecting binding events
JP2008064465A (en) Surface for biosensor
DE4013713A1 (en) Optical bio-sensor with Langmuir-blodgett film contg. fluorescent dye
JPH10505904A (en) Direct and indirect modulation of spectrophotometric changes in lipid layers in measuring analytes
DE3938598A1 (en) Optical bio-sensor - based on fluorescent energy transfer between one dye incorporated in Langmuir-Blodgett film and marker dye
Siegmund et al. An optical biosensor principle based on fluorescence energy transfer
Völker et al. Förster energy transfer in ultrathin polymer layers as a basis for biosensors
Song et al. Resonant-energy-transfer-based biosensor for detection of multivalent proteins
Kellermann et al. Photoactive hydrogels for pre-concentration, labelling, and controlled release of proteins

Legal Events

Date Code Title Description
AS Assignment

Owner name: BAYER AKTIENGESELLSCHAFT, LEVERKUSEN, GERMANY, A C

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNORS:HUGL, HERBERT;KUCKERT, EBERHARD;MOBIUS, DIETMAR;AND OTHERS;REEL/FRAME:005609/0676;SIGNING DATES FROM 19900920 TO 19901105

STCF Information on status: patent grant

Free format text: PATENTED CASE

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

CC Certificate of correction
FEPP Fee payment procedure

Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 4

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12

AS Assignment

Owner name: SIEMENS HEALTHCARE DIAGNOSTICS GMBH,GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BAYER AG;REEL/FRAME:024468/0591

Effective date: 20100226